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ABSTRACT 
Ralston M. Barnes 
THE HAND1 LINEAGE REVEALS DISTINCT ROLES FOR HAND FACTORS 
DURING CARDIOVASCULAR DEVELOPMENT 
 
The basic Helix-Loop-Helix (bHLH) transcription factors Hand1 and Hand2 
play critical roles in the development of multiple organ systems during 
embryogenesis. The dynamic expression patterns of these two factors within 
developing tissues obfuscates their respective unique and redundant 
organogenic functions. To define cell lineages potentially dependent upon Hand 
gene expression, we generated a mutant allele in which the coding region of 
Hand1 is replaced by Cre recombinase.  Subsequent Cre-mediated activation of 
β-galactosidase or eYFP reporter alleles enabled lineage trace analyses that 
clearly define the fate of Hand1-expressing cells. Comparisons between Hand1 
expression and Hand1-lineage greatly refine our understanding of its dynamic 
spatio-temporal expression domains and raise the possibility of novel Hand1 
functions in structures not thought to be Hand1-dependent. To genetically 
examine functional overlap between Hand1 and Hand2, we conditionally deleted 
Hand2 from Hand1-expressing cells. Hand2 conditional knockout mice die 
midgestation and exhibit cardiovascular and limb defects. Moreover, Hand2 
lineage-restricted deletion from the proepicardial organ results in defective 
epicardialization and failure to form coronary arteries. Together, these novel data 
demonstrate a hierarchal relationship whereby transient Hand1 expression within 
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the septum transversum defines epicardial precursors that depend upon 
subsequent Hand2 function. 
Anthony B. Firulli, Ph.D., Chair 
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Chapter One 
Introduction 
 
Overview of heart development 
The heart originates from a population of bilaterally symmetrical 
mesodermal cells located within the anterior of the early headfold-stage embryo. 
This population of cells, termed the cardiac crescent, is characterized by the 
expression of a restricted profile of transcription factors, including the 
homeodomain transcription factor Nkx2.5 and the T-box containing transcription 
factor Tbx5 (Olson, 2002). The limbs of the cardiac crescent ultimately migrate to 
fuse along the ventral midline, forming a linear tube comprised of myocardial and 
endocardial layers intervened by extracellular matrix termed the cardiac jelly.  
This tube is then patterned along an anterior-posterior axis and divided into a 
series of segments, distinguishable through their unique transcriptional profiles, 
which will give rise to the conotruncus, the right and left ventricles, the 
atrioventricular (AV) canal, and the left and right atria. As the heart tube 
lengthens, it loops to the right displacing its ventral surface, termed the outer 
curvature, laterally. As the primitive cardiac chambers mature, a subpopulation of 
endocardial cells residing within the AV canal, undergo epithelial-to-
mesenchymal transition (Kreuger et al., 2005), delaminating and invading the 
cardiac jelly to form structures known as the AV cushions (Eisenberg and 
Markwald, 1995). The mesenchymal cells of the AV cushions subsequently 
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differentiate into the fibrous tissue, which is remodeled to form the AV valves 
(Armstrong and Bischoff, 2004).  Roughly concurrent with AV cushion formation, 
neural crest-derived ectomesenchyme populating the pharyngeal arches dorsal 
to the conotruncus differentiates into smooth muscle cells that subsequently 
organize into bilaterally symmetrical blood vessels termed the pharyngeal arch 
arteries. These vessels are ultimately remodeled to form the great arteries of the 
aortic arch, the vasculature through which blood exits the heart (Hiruma et al., 
2002).  
Recent work has defined two major fields of cardiac progenitors, dubbed 
the first (FHF) and second heart fields (SHF) (Cai et al., 2003).  The FHF has 
been defined as the region of splanchnic lateral plate mesoderm that contributes 
to descendents of the left ventricle, atria, and inflow region while the SHF is 
derived from pharyngeal mesoderm cells which contribute to the right ventricle, 
OFT, and atria in a mixed population with the FHF (Cai et al., 2003; Kelly, 2005). 
Experiments in which mice lacking Islet-1 failed to extend the primitive heart tube 
confirmed that cells of the SHF are cardiogenic progenitors that contribute to 
heart development prior to neural crest contributions to the aorticopulmonary 
cushions and the smooth musculature of the OFT and aortic arch.  Lineage-
tracing experiments using an Islet-1Cre show that the SHF gives rise to 
cardiomyocytes of the OFT, right ventricle, atria, and inflow region segments of 
the heart (Cai et al., 2003; Yuan et al., 2000).   
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Overview of bHLH Proteins 
Heart fields are first specified at E7.5 when cytokines from the 
transforming growth factor beta and Fibroblast Growth Factor superfamilies 
induce cardiogenesis (Abu-Issa and Kirby, 2007). The cardiac differentiation 
program is mediated by transcription factors via a positive feed-forward 
mechanism (Bruneau, 2002; Takeuchi and Bruneau, 2009).  Numerous 
transcription factors drive cardiac specification, differentiation, and 
morphogenesis including, members of the Nkx2, Gata, Mef2, Srf, Tbx, Irx, and 
Twist families (Barnes and Firulli, 2009; Firulli and Thattaliyath, 2002; Kirby, 
2007; Takeuchi and Bruneau, 2009).   
The Twist family of basic helix-loop-helix (bHLH) group of transcription 
factors exerts a determinative influence on a variety of developmental pathways, 
notably cardiac development.  These transcription factors are characterized by a 
highly evolutionary conserved bHLH domain that mediates DNA binding and 
dimerization (Massari and Murre, 2000).  More specifically, this motif contains an 
N-terminal α-helix with 20 basic residues that interact with DNA at the canonical 
DNA sequence “CANNTG” (known as an E-box), a middle loop region, and a C-
terminal amphipathic α-helix. bHLH proteins are generally categorized into two 
main classes, class A factors, which are represented by the near-ubiquitously 
expressed E-proteins (E12, E47, HEB, ITF), and class B factors, which are 
expressed in a tissue-restricted manner (Firulli, 2003).  Dimers differ in their 
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affinity for DNA and in their ability to activate transcription from E-box-containing 
promoters. 
Brief Overviews of Hand Factors during Heart Development 
Hand1 and Hand2 Twist-family member bHLH transcription factors serve 
an important role during embryogenesis and have demonstrated a critical role for 
the Hand genes during cardiac morphogenesis (Firulli, 2003). During mouse 
cardiogenesis, Hand2 and Hand1 are expressed in a complementary fashion in 
the future right and left ventricles, respectively (Firulli, 2003).  Targeted deletion 
of the Hand2 gene in mice demonstrated a requirement for Hand2 in the 
development of cells fated to form the future right ventricle during the period of 
cardiac looping (Srivastava et al., 1997).  Hand2 null mice die between E9.5–
10.5, exhibit hypoplastic first and second arches, secondary to apoptosis, and 
the third and fourth arches fail to form (Srivastava et al., 1997; Thomas et al., 
1998).  Mice lacking the Hand1 gene die between E8.5 and E9.5 due to 
deficiencies in the extra embryonic mesoderm thereby precluding detailed 
analysis of its role in cardiogenesis (Firulli et al., 1998). Embryos homozygous for 
a Hand1 cardiac-specific conditional allele displayed defects in the left ventricle, 
endocardial cushions, and exhibited dysregulated ventricular gene expression 
(McFadden et al., 2005). No right ventricular phenotypes are evident. Intercross 
of the cardiac-specific Hand1 mutant mouse into the Hand2 systemic null allele 
shows the importance of Hand gene dosage for proper heart development. 
These mice display both left and right ventricle hypoplasia. Interestingly, this 
 5 
genetic interaction is difficult to explain, as Hand1 is never detected within the 
right ventricle, an AH-derived structure. This suggests that either Hand1 is 
expressed at low levels early in the specification of right ventricular 
cardiomyocytes or that signaling networks hobbled by Hand1 loss-of-function are 
sensitive to Hand2 haploinsufficiency.  
Hand1 is required for proper cardiac morphogenesis and is essential for 
extra-embryonic and trophoblast-cell differentiation 
 Hand1 was cloned from a yeast-2-hybrid screen using an E12 bait 
(Cserjesi et al., 1995).  Hand1 shares the highest degree of sequence identity 
with Hand2 and to a lesser extent with Twist1 and other bHLH family members 
(Srivastava et al., 1995). In Situ hybridization shows Hand1 is expressed within 
the trophoblast cells of the ectoplacental cone prior to E7.5 with expression 
throughout the yolk sac, chorion & extra embryonic mesoderm (Cserjesi et al., 
1995).  Extra-embryonic expression of Hand1 is maintained throughout later 
stages of embryonic development (Cserjesi et al., 1995).   
In the embryo, Hand1 expression is first observed at embryonic day E7.5 
in the lateral plate mesoderm that contributes to form the primitive heart tube 
(Srivastava et al., 1997).  At E8.5 Hand1 is detected in the developing heart tube, 
pericardium, & the distal regions of lateral mesoderm (Biben and Harvey, 1997, 
Cserjesi et al., 1995, Srivastava et al., 1995).  During rightward looping of the 
heart, Hand1 becomes restricted to the outer curvature of the myocardium 
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contributing to the presumptive left ventricle, the septum transversum, and the 
pericardium where it persists thru E13.5 (Cserjesi et al., 1995, Firulli et al., 1998, 
Thomas et al., 1998).  Hand1 expression continues to accumulate throughout the 
lateral mesoderm where it persists in the developing gut distal to the duodenum 
(Morikawa and Cserjesi, 2004).  Hand1 is also expressed throughout the 
umbilical and vitelline vein/artery by E9.5 (Firulli et al., 1998).  Hand1 is also 
detected in the distal portions of the limb.  At E11.5 it is expressed in the antero-
ventral domain of the limb bud where it is maintained thru E13.5 (Fernandez-
Teran et al., 2003).  Hand1 is expressed in adult-rodent and human hearts as 
well, where they are thought to play a role in preventing hypertrophy. 
Hand1 is also expressed within the cranial and cardiac neural crest cells 
occupying the medial pharyngeal arches and first appears at E9.5 as they begin 
to populate the outflow tract where they contribute to the smooth muscle lining 
the pulmonary artery (Cserjesi et al., 1995, Barbosa et al., 2007, Vincentz et al., 
2008). Hand1 continues to accumulate in structures derived from neural crest 
cells where by E10.5 it is detected in the sympathetic and splanchnic ganglia of 
the peripheral nervous system and the first and second aortic arch (Cserjesi et 
al., 1995, Firulli et al., 1998, Howard et al., 1999, Morikawa and Cserjesi, 2004).  
At E12.5, Hand1 is expressed in the sypatho/adrenal lineage as well as the 
mandible, which is derived from the pharyngeal arches (Cserjesi et al., 1995, 
Firulli et al., 1998, Morikawa and Cserjesi, 2004).  Hand1 mRNA continues to 
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persist in rudiments of neural crest derived tissues until E14.5 (Cserjesi et al., 
1995, Morikawa and Cserjesi, 2004).   
Heart development of Hand1-null mutants is arrested during formation of 
the heart tube where the caudal portion failed to fuse as shown by marker 
analysis  (Firulli et al., 1998).  Analysis of homozygous Hand1-null embryos 
shows that early myocardial markers such as Nkx2.5, Mef2C, Gata4, and Mlc2a 
were unaffected (Firulli et al., 1998, Riley et al., 1998).  Hand1-null embryoid 
bodies are capable of differentiating into cardiomyocytes (Riley et al., 2000) 
indicating that heart defects are not due to a failure of the myocardium to 
differentiate but due to improper patterning of the heart (Firulli et al., 1998).  
Tetraploid experiments using Rosa26 derived; Hand1-null ES cells are 
underrepresented in the left ventricular chamber but are capable of differentiating 
into cardiomyocytes in vitro indicating that Hand1 is not necessarily essential for 
cardiomyocyte differentiation but is required for proper patterning of the left 
ventricle (Riley et al., 2000).  Furthermore, the reduction of the left ventricle in 
mice with a conditional ablation of Hand1 in the heart substantiate this conclusion 
(McFadden et al., 2005), though more detailed analysis pairing the conditional 
Hand1-allele with a wider range of available Cre lines would be useful to support 
these findings. 
Hand1 is restricted to the outer wall of the left ventricular chamber during 
rightward looping of the heart.  An asymmetric expansion of cells in this outer 
curvature is tightly intertwined in the process, implicating a role for Hand1 in 
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proliferation during heart remodeling.  Misexpression of Hand1 in the 
myocardium of both ventricular chambers resulted in an expansion of the outer 
curvature of both the left and the right ventricle (Togi et al., 2004).  Over 
expression of Hand1 specifically in Hand1 expressing cells resulted in abnormal 
looping (Risebro et al., 2006).  Though these hearts were accompanied by a 
failure of ventricular expansion, thorough analysis revealed that Hand1 over-
expression resulted in left-ventricular defects due to elevated myocyte density 
and reduced myocardial differentiation.  Furthermore, cells over expressing 
Hand1 in Hand1-positive neural crest cells resulted in an elongated outflow tract 
due to continued proliferation and a failure to commit to differentiation (Risebro et 
al., 2006).  The complimentarity of the phenotype between loss-of-function and 
gain-of-function mutations of Hand1 suggest a conserved role for Hand1 during 
heart morphogenesis.  Additionally, they support the hypothesis that proper Hand 
gene dosage is essential for proper development, which has been elucidated in 
further studies with Hand2 (Barbosa et al., 2007, McFadden et al., 2005).   
Further analysis of Hand1 null mice clearly shows that Hand1 is essential 
for the development of extra-embryonic tissue.  Hand1 is expressed in all 
subtypes of trophoblast giant cells within the ectoplacental cone and chorion 
(Simmons et al., 2008, Vasicek et al., 2003).  Hand1-null embryos exhibit a 
dramatic downregulation of placental lactogen 1 (Pl1) within the ectoplacental 
cone.  Pl1 codes for a hormone required for embryonic viability and placental 
homeostasis and is expressed within the developing giant-trophoblast cells 
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(Cross et al., 2002, Firulli et al., 1998, Hughes et al., 2004). Pl1 was detected in 
only a subset of giant cells outside of the ectoplacental cone in the placenta of 
Hand1-null embryos (Riley et al., 1998). The ectoplacental cone only contains an 
increased number of giant cell precursors, suggesting Hand1 plays a role during 
giant cell differentiation (Gardner et al., 1973).  This conclusion gains support 
when considering that over-expression of Hand1 leads to an increase of Pl1 in 
giant cells (Cross et al., 1995) and Hand1 homozygous mutant trophoblast cells 
display deficiencies in differentiation and normal invasive behavior (Hemberger et 
al., 2004), illustrating the critical role for Hand1 in trophoblast cell development.  
Furthermore Hand1 hypomorphic alleles, which extend embryonic viability up to 
E12.5 exhibit an intermediate level of Pl1 expression when compared to wildtype 
and Hand1 null embryos (Firulli et al., 2010). 
In regard to extra-embryonic tissues, Hand1 is also required for the 
formation of the extra-embryonic membrane, where it is expressed within the 
mesodermal compartment.  Hand1-null embryos exhibit abnormalities of the 
extra-embryonic vasculature following formation of the yolk sac by E7.5 (Firulli et 
al., 1998, Morikawa and Cserjesi, 2004).  Analysis of Hand1-null embryos shows 
that the yolk sac maintains an immature vascular plexus and smooth muscle 
cells required for blood vessel support during vasculogenesis failed to undergo 
normal recruitment (Morikawa and Cserjesi, 2004).  Collectively the trophoblast 
and extra embryonic vascular phenotypes are the likely cause of embryonic 
death as the observed phenotypes within neural crest and cardiac cell 
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populations would not result in embryonic lethality until later gestation or even 
after birth. 
Mechanistically Hand1 was initially thought to interact only with 
ubiquitously expressed E-proteins (Massari and Murre, 2000).  Mammalian two-
hybrid and pull-down assays confirmed however, that Hand1 could form 
homodimers as well as interact with other tissue restricted bHLH proteins, such 
as Hand2 (Firulli et al., 2000) and later Twist1 (Firulli 2005).  Similar to Twist1, 
Hand1 was shown via EMSAʼs to inhibit MyoD/E12 DNA-binding presumably by 
directly competing for E-protein and MyoD dimers  (Firulli et al., 2000). Although 
the biological relevance of this observation is moot given Hand1 and MyoD are 
not co-expressed during development, it does speak to the evolutionary 
conservation within the Twist-family and their ability to alter the bHLH dimer pool 
within a cell simply by reorganizing the dimer partner complexes by regulating 
their dimer choices. The idea of dimer regulation as a mechanism to control 
biological developmental programs was then postulated and the evidence of such 
regulation was then sought. 
Dimer partner choice must infer dimer regulation on Twist family proteins 
and this was first demonstrated with Hand1.  The LIM domain protein FHL2 is 
capable of interacting with Hand1 in the nucleus and repressing function of 
Hand1/E12 heterodimers though it is incapable of effecting Hand1/Hand1 
homodimer activity (Hill and Riley, 2004).  Additionally, gain-of-function 
expression of a DNA-binding mutant Hand1 protein does not inhibit Hand1ʼs 
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ability to induce limb polydactyly suggesting that alteration of the bHLH dimer 
pool is more influential on biological program then direct cis-acting targets for 
functional Hand1 transcriptional complexes (McFadden et al., 2002).   Indeed 
when considering these results carefully, the most plausible mechanism to 
explain these findings would be that Hand1 dimerization acts as a dominant 
negative factor antagonizing the equilibrium of the bHLH dimer pool. Support of 
this model is observed in gain-of-function experiments that show expression of a 
Hand1 proline mutant, which disrupts the HLH domain does not result in 
polydactyly  (McFadden et al., 2002) 
If altering the overall expression level of Twist-family proteins can alter the 
bHLH dimer pool within the cell when expression levels are within normal levels, 
are there additional mechanisms that control dimer choice? Indeed post-
translational modification of Twist proteins influences dimer complex formation:  
Hand1 phosphoregulation at Serine 107 and Threonine 109 modulates dimer 
partner specificity. Protein Kinase A and C (PKA and PKC) which can 
phosphorylate these Hand1 residues while b56d-containing Protein Phosphatase 
2A (PP2A) can specifically dephosphorylate these residues (Firulli et al., 2003).  
Phosphorylation of Hand1 increases during differentiation of trophoblast giant-
cells and this is associated with a downregulation of b56d (Firulli et al., 2003).  
Recently, it has been shown in trophoblast giant-cells that Hand1 is negatively 
regulated by interacting with I-mfa, which sequesters it to the nucleolus (Martindill 
and Riley, 2008, Martindill et al., 2007). Interestingly, the Hand1 
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hypophosphorylation mutant targets directly to the nucleolus where the protein is 
sequestered, preventing differentiation (Martindill and Riley, 2008, Martindill et 
al., 2007).  Conversely a Hand1 phosphorylation mimic resides solely within the 
nucleus and expression drives trophoblast differentiation (Martindill and Riley, 
2008, Martindill et al., 2007). This data demonstrates that phosphoregulation 
modulates dimer choice in at least two ways. First by directly effecting protein 
affinity and second my dictating cell localization.  
To date, upstream regulators and downstream transcriptional targets of 
Hand1 have been difficult to ascertain. Hand1 in vitro can activate the promoter 
of cardiac atrial natriuretic factor, implicating it as a potential target of Hand1 
(Morin et al., 2005).  Hand1 is coexpressed in the heart with Thymosin b4, which 
is downregulated in Hand1-null embryoid bodies, as well as cytostatin C, and 
aCA, which are found to be upregulated (Smart et al., 2002).  Ectopic expression 
of Tbx5 results in enhanced Hand1 expression while simultaneously suppressing 
Hand2, suggesting that Tbx5 can impart left ventricular identity upon Hand1 
expressing cells found throughout this region (Takeuchi et al., 2003).  Regarding 
upstream regulation, Nkx2.5 knock-out mice, which regulates expression of a 
number of cardiac specific genes, results in a severe reduction of Hand1 in the 
heart, implicating that Nkx2.5 may be upstream of Hand1 (Tanaka et al., 1999).   
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Hand2 is Required During Development of the Heart, Limbs, Autonomic 
Nervous System, & Other Neural Crest Derived Structures 
 Hand2 was identified in a low stringency cDNA library screen using a 
Hand1 bHLH domain probe (Srivastava et al., 1995).  In the chick, Hand2 is first 
detected in the lateral mesoderm, and cardiac crescent; later it is expressed 
throughout the developing heart tube (Srivastava et al., 1995). In the mouse, 
Hand2 is first expressed at E7.5 in the maternally derived decidua and is first 
detected in the embryo at E7.75 in the lateral mesoderm that forms the cardiac 
crescent and is maintained throughout the linear heart tube to E8.0 (Srivastava et 
al., 1997). At the onset of cardiac looping, Hand2 cardiac expression 
subsequently restricts to the forming right ventricle and outflow tract 
downregulating within the left ventricle, which expresses Hand1 (Firulli et al., 
1998, McFadden et al., 2000, Overbeek, 1997, Srivastava et al., 1997).  Hand2 is 
also expressed in the pharyngeal arches and neural crest cells where they give 
rise to craniofacial structures, outflow tract, the sympathetic nervous system, 
extra-adrenal chromaffin cells, as well as the posterior portion of the limb buds, 
(Charite et al., 2000, Gestblom et al., 1999, Ruest et al., 2003).   
 Hand2-null embryos die by E9.5 suffering with severe morphological 
deficiencies in the heart as they have only a single left ventricle (Srivastava et al., 
1997).  Hand2-null embryos undergo apoptosis in the region of the forming right 
ventricle (bulbous cortis) and results in a down regulation of ventricular markers 
such as Irx4, suggesting a role for maintenance of the right ventricle progenitors 
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and supporting ventricular expansion (Bruneau et al., 2000, McFadden et al., 
2000, Yamagishi et al., 2001).  This role for Hand2 is further supported by 
evidence that a conditional deletion of Gata4 in the heart, which has been shown 
to directly regulate a ventricular enhancer element of Hand2, results in right 
ventricular hypoplasia (McFadden et al., 2000, Zeisberg et al., 2005).  
Overexpression of Hand2 in the ventricles results in outward expansion of the 
ventricular chamber as well as an absence of the interventricular septum, which 
is replaced by an expanded trabecular domain, further establishing a role for 
Hand2 in supporting ventriculogenesis (Togi et al., 2006). In mice that have a 
homozygous-null allele for m-Bop, the histone deacetylase-dependent 
transcriptional repressor, Hand2 expression is down regulated and there is an 
associated disruption of ventricular myocardial development (Gottlieb et al., 
2002). Data that may partially explain the Hand sided expression can be seen in 
studies of Tbx5 (Takeuchi et al., 2003). Tbx5 can suppress Hand2 concurrent 
with upregulation of Hand1.  
 Hand2 has been shown to directly regulate the Nppc gene which codes of 
atrial naturetic factor (Anf).  In Hand2-null mice, Anf is downregulated while a 
Hand2-heterodimer has been shown to trans-activates the Anf promoter 
(Thattaliyath et al., 2002a). Additionally, Hand2 cooperates with Mef2c to activate 
both Anf and aMHC (Zang et al., 2004a, Zang et al., 2004b).  Moreover, Hand2 
can synergize with Gata4 to activate Anf as well, revealing a multifunctional role 
for Hand2 in Anf regulation (Dai et al., 2002).   
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 Recently, it has been demonstrated that Hand2 is a direct target of 
microRNAs.  A heart conditional knock out of Dicer, an enzyme required for 
processing of precursor microRNAs, results in the upregulation of Hand2 (Zhao 
et al., 2007).   miR-1, a cardiac and skeletal muscle-restricted microRNA, is 
negatively affected in the Dicer knockouts.  miR-1  over expression leads to a 
reduction in ventricular myocardium and is also capable of directly targeting 
Hand2 (Zhao et al., 2005). 
  Hand2 is also expressed throughout the cephalic neural crest 
mesenchyme of the first and second pharyngeal arches and plays a role in facial 
morphogenesis, where expression is directed by a Hand2 enhancer element 
complete and separate from the ventricular heart enhancer (McFadden et al., 
2000, Ruest et al., 2003, Yanagisawa et al., 2003).   Endothelin-1 (Edn1), which 
is expressed in the epithelial layer of the branchial arches, regulates Hand2 and 
is downregulated in the branchial arches in Edn1-null mice (Ivey et al., 2003, Li 
and Li, 2006, Thomas et al., 1998a).  The Edn1 downstream effectors Dlx5 & 
Dlx6 directly regulate Hand2 transcription via a Dlx cis-element located within the 
Hand2 branchial arch enhancer (Charite et al., 2001, Fukuhara et al., 2004).  
Targeted deletion of the Hand2 branchial arch enhancer confirms that Hand2 is 
required for craniofacial development as mutants exhibit craniofacial 
abnormalities that include cleft palate, mandibular hypoplasia, as well as a range 
of cartilage malformations (Yanagisawa et al., 2003).  A small domain of Hand2 
expressing cells in the distal most portion of the pharyngeal arches appears to be 
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Edn1 independent and is instead thought to be regulated by GATA3 (Ruest et al., 
2004).  A conditional neural crest cell deletion of Mef2c shows that Mef2c likely 
mediates Endothelin signaling in the pharyngeal arches and is required for Dlx 5 
& 6 and Hand2 (Verzi et al., 2007).  Pharyngeal arch mesenchyme undergoes 
apoptosis in Hand2-null embryos by E9.5; however cell death is partially rescued 
when mice are also null for Apaf1 (Aiyer et al., 2005, Thomas et al., 1998a).   
 Hand2 is necessary for limb morphogenesis.  Hand2 is expressed in the 
posterior portion of the developing limb buds in the signaling region called the 
zone of polarizing activity (ZPA) (Charite et al., 2000, Fernandez-Teran et al., 
2000).  It has been implicated that retinoic acid signaling first establishes Hand2 
in the ZPA (Mic et al., 2004).  Hand2 can upregulate expression of Sonic Hedge 
Hog (Shh) in the ZPA and expression of Shh upregulates expression of Hand2.  
Overexpression of Hand2 in the limb buds results in polydactyly associated with 
expanded Shh expression which results in ectopic ZPA formation (Charite et al., 
2000, Fernandez-Teran et al., 2000, McFadden et al., 2002) while Hand2-null 
embryos lack any detectable Shh expression domain (Charite et al., 2000).  
Hand2 also upregulates the BMP antagonist Gremlin, which acts to maintain an 
Shh/FGF feedback loop that maintains the ZPA (McFadden et al., 2002, Zuniga 
and Zeller, 1999).  The Shh repressor Gli3 helps to restrict Hand2 expression to 
the ZPA, which in turn feedbacks to regulate Gli3, allowing Shh signaling (Liu et 
al., 2005).   Additional factors that potentially regulate Hand2 in the limb are Tbx3 
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and Hoxd13 and due to their coexpression Twist1 (Rallis et al., 2005, Salsi et al., 
2008 Firulli et. al., 2005).   
 Hand2 is expressed in multiple derivatives of neural crest cells, including 
the peripheral nervous system.  Specifically, Hand2 has been implicated in 
specification and maintenance of the noradrenergic phenotype of the sympathetic 
nervous system and chromaffin cells of the sympathoadrenal lineage 
development (Huber et al., 2002, Xu et al., 2003).  Ectopic expression of Hand2 
is capable of activating the noradrenergic program (Howard et al., 1999, 
Morikawa et al., 2005).  BMPʼs have been implicated in activating the 
noradrenergic phenotype and several of the transcription factors regulating 
sympathetic differentiation, including Hand2 (Howard et al., 2000, Liu et al., 
2005b, Muller and Rohrer, 2002). Unlike other transcription factors expressed 
during sympathetic neurogenesis that are responsive to BMPʼs which include 
Phox2a, Phox2b, and Mash1, only Hand2 is exclusive to noradrenergic 
differentiation. Cilliary neurons lacking Hand2 expression become cholinergic in 
response to BMP (Muller and Rohrer, 2002).   Additionally, mesenchephalic 
neural crest cells that are Hand2-negative cannot differentiate into 
catecholaminergic neurons (Lee et al., 2005).  
These studies suggest a role for Hand2 specifying and maintaining the 
noradrenergic phenotype during catecholaminergic differentiation.  Additional 
evidence to support this hypothesis is that Hand2 directly transactivates 
Dopamine β-Hydroxylase (DBH) in conjunction with Phox2a (Rychlik et al., 2003, 
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Xu et al., 2003).  Conditional knockouts of Hand2 in neural crest cells reveals that 
sympathetic precursors differentiate into neurons but fail to express 
noradrenergic biosynthesis enzymes, such as DBH, further suggesting a role in 
the determination of the catecholaminergic phenotype (Hendershot et al., 2008, 
Morikawa et al., 2007).  In the enteric nervous system, gain-of-function of Hand2 
results in an overall increase of neurogenesis, suggesting it may have the 
potential to drive the noradrenergic phenotype; however, Hand2 loss of function 
suggests that Hand2 neural crest migrate properly and express neurogenic 
markers but fail to terminally differentiate, again suggesting a role for Hand2 in 
specification and maintenance of the noradrenergic phenotype (D'Autreaux et al., 
2007, Hendershot et al., 2007). In Zebrafish, there is only a single hand gene 
most identical to Hand2. A mutation of Hand2, called Hands off, shows that 
sympathetic precursors migrate properly and undergo proper neurogenesis, but 
ultimately fail to express noradrenergic genes indicative of terminal differentiation 
of catecholaminergic neurons (Lucas et al., 2006).    
 As with all Twist-family bHLHʼs, Hand2 is capable of forming heterodimers 
with E proteins to regulate transcription (Dai and Cserjesi, 2002).  Though E-
proteins are near ubiquitously expressed in embryonic tissue, they are expressed 
at lower levels in the heart, suggesting that Hand2 potentially dimerizes with 
other bHLH proteins or other factors to regulate development in heart tissue 
(Murakami et al., 2004).  Among these potential dimer partners, it has been 
shown that Hand2 can heterodimerize with Hand1 and potentially acts as an 
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inhibitor, imparting a multifunctional role on Hand factors (Firulli et al., 2000).  
GATA4 has also been shown to synergize with Hand2 to activate Anf through a 
direct interaction with P300 (Dai et al., 2002).  The ability of Hand2 to 
transactivate is enhanced through stabilization when bound to DNA by JAB1 (Dai 
et al., 2004).   
 Phosphoregulation also regulates dimerization of Hand2.  As previously 
discussed in Twist1, phosphorylation alters the dimerization preference of Hand2, 
mediated by PKA, and directly influences the antagonistic relationship with 
Twist1 (Firulli et al., 2003, Firulli et al., 2005). BMPʼs regulate Hand2 via induction 
of PKA, which phosphorylates the conserved helix 1 threonine and serine 
promoting noradrenergic differentiation from a specified cell type (Liu et al., 
2005).  
Cre Recombinase as a Necessary Tool for Lineage Conditional Studies 
 Conventional gene targeting generates a mutant allele in all cells of the 
mouse following fertilization.  This serves as an extremely useful tool for 
investigating gene function during development.  However, difficulties can be 
encountered, such as embryonic lethality, and analysis can be complicated due 
to indirect effects from ablating the gene in all tissues.  The P1 bacteriophage 
protein Cre is capable of mediating site specific recombination at loxP sites found 
in their genome and has applications for use in the mammalian system.  To date, 
the Cre-loxP system is the best characterized means of achieving conditional 
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gene inactivation in mice and has contributed extensively as a tool for altering the 
mammalian genome.   
Site-specific recombination mediated by the integrase family of enzymes 
plays a central role in the life cycles of temperate bacteriophage, bacteria, and 
yeasts (Landy, 1993).  This includes the integration into and excision from the 
host chromosome of phage genomes, in stable partitioning of plasmid, phage, or 
bacterial genomes, in effecting developmental switches in gene expression and 
in the copy number control of yeast plasmids via replication amplification 
(Yoziyanov et al., 1999).  The P1 bacteriophage site-specific recombination event 
mediated by Cre and its recognition sites (called loxP) were originally identified 
through a series of mutagenesis studies in the early 1980ʼs (Sternberg and 
Hamilton, 1981).  For most of the decade, the mechanism surrounding Cre-
mediated recombination and its interaction with the loxP site were vigorously 
studied and ultimately delineated.  Though Integrase type recombinase have not 
been found in higher Eukaryotes, the research of Professor Brian Sauer while at 
DuPont lead to the development of the Cre-LoxP recombinase technology and its 
functional application in the eukaryotic genome after a series of in vitro cell 
culture experiments in PK15 cells (Sauer and Henderson, 1988).  These 
experiments were followed by the demonstration that the Cre recombinase 
worked in vivo when a transgenic Cre mouse line was used to activate a dormant 
transgene flanked by loxP sites, causing tumorigenesis (Lasko et al., 1992).  
Ultimately the development of the Cre-loxP recombinase system has 
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revolutionized mouse genetics by proving to be an essential tool for conditional 
genetic alteration in mice.   
The Cre Recombinase Protein Catalyzes Site-Specific Recombination of 
loxP sites 
Integrase family members cleave their DNA substrates by a series of 
staggered cuts (Guo et al., 1997).  Very little sequence similarity is shared 
between these members, except for four residues required to catalyze the 
reaction (Abremski and Hoess, 1992).  It has been suggested that the 
dissimilarity of sequence between Integrase family members is due to the 
overwhelming diversity in the function and manner in which these proteins carry 
out their recombination function. The lysogenic phase is characterized by the 
fusion of the nucleic acid of a bacteriophage with that of a host bacterium. The 
newly integrated genetic material, called a prophage, can be transmitted to 
daughter cells at each subsequent cell division (Ikeda and Tomizawa, 1968).The 
role of the Cre recombinase in the P1 bacteriophage has been to maintain the 
phage genome as a monomeric, single-copy plasmid in the lysogenic state and 
aid in the circularization of the linear P1 DNA following infection and the 
breakdown of P1 dimers that form during recombination following replication 
(Abremski et al., 1983).  
The Cre-loxP site-specific recombination system of bacteriophage P1 
consists of a site at which recombination takes place, loxP, and a phage encoded 
 22 
protein that mediates the reaction, Cre (Sternberg and Hamilton, 1981).  The Cre 
recombinase of the P1 bacteriophage belongs to the integrase family of site-
specific recombinases. Integrases are enzymes that facilitate the sequential 
exchange of DNA strands resulting in an chromosomal integration or excision 
event.  Some examples include: λ  Integrase, HP1 Integrase, XerD and Flp in 
addition to Cre recombinase.  Cre is a 38kD protein, encompassing 341 amino 
acids (Hamilton and Abremski, 1984).  It is comprised of 4 subunits with a N-
terminal and C-terminal domain.  The C terminal domain serves as the catalytic 
site of the enzyme (Guo et al., 1997).   
LoxP is a site on P1 bacteriophage DNA where recombination occurs and 
is the substrate for the Cre recombinase protein which catalyzes recombination 
between two sites.  The loxP site is 34 base pairs in length and consists of two 
13 base pair inverted repeats separated by an 8 base pair spacer region (Hoess 
et al., 1986).  The perfect 13 base pair repeats impart the directionality of the 
loxP site on the spacer region.  Another DNA integration site is found in P1 called 
loxB.  Though Cre can mediate integration at this site, it occurs at a very low 
frequency compared to the extraordinary efficiency of the loxP site as determined 
in paired phage crosses (Abremski et al., 1983; Sternberg and Hamilton, 1981).   
Cre recombinase binds to the loxP site to initiate recombination.  When 
DNA containing the loxP site is incubated with the Cre enzyme, specific cleavage 
occurs within the spacer region, creating a six base-pair staggered cut during 
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recombination (Hoess and Abremski, 1985).  The cuts are centered on the axis of 
symmetry between the two strands and results in a protruding 5ʼ end: 
 
5’ A↓T-G-T-A-T-G C 3’ 
3’ T A-C-A-T-A-C↑G 5’ 
 
The placement of the cut two base pairs from the end of the spacer sequence 
coincides with the region of strand exchange.  The relationship of the cleavage 
site to the location of the strand exchange strongly argues against the cleavage 
products being randomly generated by Cre.   
During recombination two Cre recombinase molecules becomes 
covalently attached to the 3ʼ end of each DNA strand at the point of cleavage.  
Each Cre protein contacts the 15 outermost base pairs and the first 2 base pairs 
of the spacer region (Guo et al., 1997).  Deletion experiments have shown that 
sequences outside of the inverted repeats of loxP can be removed without loss of 
recombination.  Furthermore, base pair mutations within either homologous arm 
or within the 2 base pairs of the spacer confirm that they  are required for 
recombination to occur suggesting that these sites are necessary for Cre 
interaction at loxP (Hoess et al., 1986). 
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Though the Integrase family of recombinases shares little amino acid 
homology, secondary structural alignments indicate a large conservation of 
peptide motifs within which specific residues have been retained throughout the 
family.  Specifically, they contain a four amino acid conserved region consisting 
of two arginines, one histidine, and one tyrosine (Guo et al., 1997). The tyrosine 
residue is responsible for breaking the DNA chain to form a 3ʼ-phosphotyrosine 
bridge and expose an adjacent 5ʼ hydroxyl.  This frees up the 5ʼ-OH of cleaved 
strand.  The phospho-tyrosine bond then becomes the target of attack by the 5ʼ-
hydroxyl group from the cleaved strand of the partner DNA during the strand 
joining step of recombination group (Yoziyanov et al., 1999).  
Cleavage resulting in a break of a phosphodiester bond 3ʼ to the 
phosphate and simultaneous covalent attachment between DNA and protein is a 
feature shared with other topoisomerases and is a means by which bond energy 
is preserved following cleavage to allow for rejoining without an external energy 
source (Hoess and Abremski, 1985). Since Cre recombinase is the only protein 
required and the reaction does not require an external energy source, it is a very 
efficient reaction.  Early experiments using an EcoRI restriction fragment 
containing flanking loxP sites showed that Cre recombinase could efficiently and 
specifically excise the flanked DNA fragment (Sternberg and Hamilton, 1981).  
The independence from energy co-factors and the high fidelity of the reaction 
make this an extraordinarily sound system to initiate recombination. 
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Cre recombinase is capable of mediating recombination at loxP sites.  The 
specific action that takes place ultimately depends on the orientation of two loxP 
sites with one another.  Deletion experiments have shown that the region flanking 
the loxP sites are not important for the recombination event to occur (Hoess et 
al., 1986).  Since the loxP site contains two palindromic arms, directionality is 
ultimately determined by the spacer sequence.  The cleavage event creates a 6 
base pair overhang that requires a specific configuration to bind the reciprical 
strand.  In the event that the loxP sites are located in the same orientation and on 
the same strand, the flanked DNA will be excised in a circular fashion.  The Cre 
molecules bound to the C-terminal loxP site will loop to form an intermediate 
interface with the N-terminal loxP sites that is stabilized by the Cre-DNA 
interactions before the recombinases join the flanking strands and excise the 
flanked DNA (Guo et al., 1997).  In the event that the loxP sites are positioned in 
an opposing orientation, the cleaved strands will only be able to join in such a 
manner as that it causes an inversion of the flanked DNA.   
Cre-loxP Recombinase Is A Powerful Reagent For Tailoring The Genome 
The highly specific relationship and function coupled with the efficiency of 
the reaction makes the Cre-loxP recombinase a powerful application in the 
mouse genome.  The mammalian genome does not contain Integrase type site 
specific recombinases (Nagy, 2000).   Therefore, the application of the Cre 
recombinase system is reliant on the absence of loxP sites in mice.  The random 
occurrence of a specific 34 base pair sequence requires a 1018 base pair length 
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of DNA.  The entire mammalian genome is only 3 X 109 base pairs (Nagy, 2000).  
This suggests that it is highly unlikely that a loxP site will be present outside of 
the phage genome.  Therefore, the introduction of loxP sites to the eukaryotic 
genome will be highly specific and in combination with Cre should allow the 
achievement of specific genome alterations. 
Cre recombinase is only one member of an entire family of integrase 
recombinases.  There are other family members that are also independent of 
energy co-factors and that exhibit a high frequency of recombination, such as Flp 
recombinase.  Flp recombinase has been used successfully in Drosophila.  
However, these recombinases have a disadvantage in that they are not as 
effective in the mammalian genome (Rossant and McMahon, 1999).  One 
problem may be that the Flp protein is not be optimized for use in the mammalian 
cell.  Flp recombinase does work and serves a role in mammalian cells on the ES 
cell level in the removal of a selectable marker. Further developments in the 
enhancement of Flp recombinase hold promise for optimal use in the mammalian 
genome. 
One use for the Cre-loxP recombinase system is the removal of selectable 
markers.  Classical gene targeting relies upon the use of a positive selection 
marker in the targeted locus for ES cell selection to generate a systemic knock-
out.  It must always be considered that selection marker expression from this 
locus could potentially affect the mutant phenotype.  Flanking the positive 
selection marker, such as neomycin, with loxP sites allows for the excision of the 
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selection marker following the identification of the properly targeted allele.  
Transient expression of Cre recombinase in vitro works efficiently to remove the 
selection marker and provides the advantage of a clean allele with which to study 
(Sauer and Henderson, 1988).   
The most anticipated and obvious use for the Cre-loxP recombinase 
system comes from the ability to generate conditional or cell-type specific 
mutagenesis of the muse genome.  There are several reasons for this.  First and 
foremost, systemic germline mutations have the overwhelming potential to be 
lethal.  In this event, there is no mouse to study.  Secondly, a gene may be 
expressed in different developmental programs and in different cell types.  In this 
case, the systemic knock-out presents a complex phenotype that may be riddled 
with secondary defects that are compounding a phenotype.  Essentially, this 
creates a situation where the initial stages in which the gene plays a role but not 
necessarily the later stages may be available for concrete analysis.   
The strategy for the conditional targeting of genes is to flank a target gene 
or gene segment with loxP sites in ES cells by classic gene targeting and 
deleting the selection marker gene by transient transfection with a Cre or Flp 
expressing plasmid (Nagy, 2000).  This results in a mutant mouse carrying a 
functional, loxP flanked gene.  To remove the selection marker, either three-loxP 
sites can be used or flanking the selection marker with frt sites for excision using 
a Flp expressing plasmid is an alternative.  Though this is a simple idea, there 
are serious potential problems, which can be encountered.  The most relevant 
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problem is that the loxP sites need to be targeted in such a manner that they can 
delete critical regions of DNA such that protein function is ablated.  The safest 
manner in which to do this is to flank the entire gene, though this can be meet 
with great difficulty in large (<100kb) multi-exon genes.  In light of this event, 
flanking of a vital exon, one encoding the translational start, is a proven 
alternative approach.  The second problem that requires serious consideration is 
that the unrecombined gene be kept fully functional.  Problems can be 
encountered when the loxP site is targeted into the middle of a conserved 
regulatory element, which can affect normal gene regulation. 
The conditional knockout of a gene can be achieved by crossing the 
conditional mutant animal with a Cre transgenic mouse line or one expressing 
Cre recombinase targeted to a genes endogenous regulatory elements.  The 
advantage of placing Cre under control of a lineage specific promoter is that it 
achieves a spatial restriction of recombination, allowing researchers to more 
accurately address their questions by pinpointing specific cell types.  This system 
can achieve further enhancement when a Cre recombinase is fused to a mutated 
estrogen receptor, which has lost its ability to bind estrogen but can still bind the 
antagonist tamoxifen (Danielian et al., 1998). The nuclear localization capabilities 
of estrogen allow the researcher to regulate Cre expression in a temporal manner 
and address the multiple roles of gene function at different time points in 
development or to circumvent embryonic lethality. 
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There are certain limitations and considerations when using a Cre 
expressing mouse line.  The first is whether the Cre line is sufficient to 
recapitulate endogenous gene expression and to drive Cre at a high enough level 
for excision to take place.  Transgenic mice can often encounter difficulties with 
poor expression as a result of their random integration while Cre needs to be 
expressed at a sufficiently high enough level for recombination to occur. 
Therefore there may be a degree of mosaiscim in expression where excision may 
not be 100% efficient.  Additionally, one must consider the extent to which the 
promoter element overlaps the endogenous gene expression and whether the 
gene of choice will be expressed in all cells.  For instance, there are multiple 
neural crest Cre drivers, however, each of them has a unique expression profile 
that when used to delete a specific genes can result in a range of phenotypes.  
An additional consideration is that the Cre-mediated excision event takes time 
and is not an instantaneous event.  The Cre protein has to be translated and built 
up to a sufficient level to ensure that an excision event takes place.  Following 
excision the gene of interest will be eliminated, but some mRNA may still linger 
for translation.  This means that there should be a delay between the onset of 
Cre transcription and the actual biological effects which researchers need to 
consider (Nagy, 2000).   
The Cre-loxP system has been utilized for the generation of conditional 
activation expression mice. Initially this approach was used to generate reporter 
mice that would permanently mark real-time expression as well as all daughter 
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cells derived from these expressing cells.  These mice contain a loxP-STOP 
cassette that interrupts transcription of a reporter gene such as β-galactosidase 
or eGFP/eYFP/eCFP.  Targeting of this construct to a ubiquitously expressed 
allele has enabled the research community to fate map specific cell lineages with 
the appropriate Cre-driven mouse line.  Upon excision, the ubiquitous promoter 
elements direct control of the reporter gene.  Since this is an alteration of the 
genomic DNA, this alteration is permanent, allowing the reporter to be expressed 
permanently following the transient activity of Cre recombinase.  The ubiquitous 
Rosa-26 gene trap integration site has been successfully targeted with a series of 
Cre excision conditional reporters that have been shown to work successfully as 
a reporter (Soriano, 1999).  Furthermore, conditionally active alleles can be 
generated using the STOP cassette strategy. 
 The Cre-loxP system has shown that it is a valuable tool for genetically 
altering mice.  It has enabled the research community to achieve optimization of 
spatial and temporal expression of genes as well as the ability to fate map cell 
lineages in mice – something once exclusive to avian and zebrafish.  The 
mechanism that Cre operates by allows it to perform efficiently on the 
mammalian genome without imparting its own phenotypic effect.  In light of the 
benefits within Cre recombinase, the potential problems and downfalls that are 
encountered with the Cre-loxP system must always be considered.  Generation 
of Cre and conditional loxP mice are often more laborious that in traditional 
cloning.  The multitude of parts and different alleles presents many opportunities 
 31 
for careless oversight to create technical difficulties.  However, properly designed 
experiments should not face these difficulties and should leave the researcher 
with a set of powerful genetic tools to conduct experiments.  
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Hand1 Lineage Analysis 
 
Generation of Hand1EGFPCreΔNeo/+ mice 
 To follow the fate of cells that express Hand1, we targeted an eGFPCre 
fusion protein expression cassette to the Hand1 locus in a murine ES cell line via 
homologous recombination (Fig. 1A). Following neomycin selection, targeting 
was confirmed in ES cell clones via Southern blot analysis (Fig. 1B). Properly 
targeted ES cells display a single 10Kb Cre cassette-containing EcoRI RFLP in 
the absence of secondary sites of insertion (Fig. 1C). Two targeted ES clones 
were injected to host blastocysts to generate first chimeric mice and then 
germline Hand1EGFPCreΔNeo/+ allelic transmission. Removal of the neomycin 
resistance cassette, via intercross with FLPeR mice (Farley et al., 2000), resulted 
in a detectable Hand1EGFPCreΔNeo/+ RFLP size shift (Fig. 1D). Both mouse lines 
expressed Cre identically, and we thus employed only one of these lines for 
these studies. eGFP mRNA expression, detected via in situ hybridization, 
correlates precisely with that of Hand1 (Fig. 1E,F). Hand1EGFPCreΔNeo/+ mice are 
viable and fertile but must be maintained as heterozygotes as homozygotes are 
null for Hand1 and thus die embryonically (Firulli et al., 1998). 
The Hand1 Lineage contributes to a subset of the FHF and epicardium 
   To test the fidelity of the Cre expression in  Hand1EGFPCreΔNeo/+ mice, we 
intercrossed Hand1EGFPCreΔNeo/+ males with R26R-β-galactosidase (β-gal) 
homozygous female mice and compared β-gal reporter activity with both real 
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time Hand1 mRNA expression and β-gal activity from the Hand1LacZ allele (Fig. 
2). At E9.5, both whole-mount and section analyses shows no significant 
difference between real-time and Hand1-lineage expression (Fig. 2A,E,I,C,G, 
and K). As expected, both Hand1 expression and lineage mark the First heart 
field (FHF) derived left ventricle, showing little expressional overlap with the 
Hand2-expressing SHF (Morikawa and Cserjesi, 2008).    Interestingly, at E10.5 
Hand1-lineage departs from real-time Hand1 expression. In whole mount, the 
entire heart appears to be Hand1-lineage positive, which would superficially 
suggest an upregulation of Hand1 within the SHF (Fig. 2F). However, section 
analysis discounts this observation, revealing a right ventricular myocardium 
largely devoid of LacZ activity (Fig. 2K). Rather, the epicardium is robustly LacZ 
stained in Hand1EGFPCreΔNeo/+ embryos in contrast to Hand1LacZ/+ embryos, which 
show no detectable epicardial LacZ staining (Fig. 2H). Thus, cells that expressed 
Hand1 during their maturation ultimately contribute to cardiac epicardium.   
 We then examined E15.5 and adult myocardial tissues to assess the 
contributions of the Hand1-lineage to both the late embryonic and the fully 
formed heart (Fig. 3A-B). At these stages, the Hand1-lineage continues to mark a 
portion of the inner wall of the interventricular septum (IVS) and the left 
ventricular myocardium. LacZ staining is not detected in adult atrial 
cardiomyocytes, indicating that the Hand-lineage does not mark cardiomyocytes 
within the entire FHF, but only a subset that contributes to the left ventricle. 
Consistent with earlier time points, SHF derived right ventricular myocardium 
shows no evidence of Hand1-expression and, with the exception of a small 
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population of SHF derived cardiomyocytes within the myocardial cuff, there is a 
near exclusion of Hand1 expression from this population of pharyngeal 
mesoderm-derived Hand2-expressing myocardium (McFadden et al., 2000; 
Srivastava et al., 1995). 
 Both in situ hybridization and Hand1LacZ staining fail to detect Hand1 within 
the endocardial or epicardial lineages. We performed immunohistochemistry to 
detect co-expression of Flk1, a marker of both of these cell types, and 
Hand1EGFPCreΔNeo/+ activated eGFP fusion protein to carefully examine whether 
the Hand1-lineage contributes to the endocardium or coronary endothelium (Fig. 
3C-H). Consistent with the lack of detectable real-time expression, no Flk1-
positive endocardial or coronary vessel cells coexpressed eGFP. 
LacZ staining of the Hand1-lineage was also not detected within the atrial 
myocardium. Immunohistochemistry for the Hand1-lineage did not mark the atrial 
myocardium, validating this observation (Fig. 3I-K). Together, these data provide 
a new perspective on the contributions of Hand1-expressing lineages to the heart 
where, with the exception of the myocardial cuff, Hand1 is excluded from SHF 
myocardium, is restricted to a ventricular subpopulation of the FHF, and marks 
both the progenitors and derivatives of the proepicardial organ and epicardium. 
More importantly, these data define more restricted spatiotemporal expression 
overlap with the related Hand1-interacting factor, Hand2. 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The Hand1-lineage marks specific subpopulations of cranial, cardiac and 
trunk neural crest, but not vagal/sacral neural crest 
Hand1 and Hand2 expression is observed within subpopulations of 
cranial, cardiac, trunk, and vagal/sacral NCCs that contribute to the jaw, cardiac 
OFT, sympathetic nervous system and enteric nervous system, respectively (Abe 
et al., 2002; Barbosa et al., 2007; Hendershot et al., 2008; Holler et al., 2010; 
Morikawa and Cserjesi, 2008; Morikawa et al., 2007; Yanagisawa et al., 2003). 
This expression can be observed in whole mount Hand1LacZ expression at E12.5 
(Fig. 4A).  Craniofacial expression of Hand1 at E12.5 is restricted to the midline 
of both the developing tongue and the mandibular process, and at E14.5 it is still 
expressed in the midlines of both the tongue and the Meckel’s cartilage in the 
mandible (Fig. 4B, C, E, and F). Comparisons of real-time Hand1 expression to 
the Hand1 craniofacial lineage at E14.5 show that the Hand1-lineage marks a 
wider subset of tissue within the tongue and the entirety of Meckel’s cartilage in 
the mandible (Fig. 4D, G).  This suggests that Hand1 may influence formation of 
midline features of both the tongue and lower jaw. 
Hand1 real-time expression within the OFT and pharyngeal arches of 
E10.5 mouse embryos is subtly distinct from that of the Hand1-expressing cNCC 
lineage (Fig. 4H, I). Medial cNCC within the forming aortico-pulmonary septum 
show an indistinguishable distribution of Hand1-expressing/marked cells. 
However, Hand1LacZ expression is observed in approximately 50% of cNCC 
occupying the OFT, while almost all of these cells are marked as having derived 
from the Hand1-lineage suggesting that Hand1 real-time expression is 
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downregulated as cNCC migrate into the OFT (Fig. 4B). This finding is consistent 
with previously published observations (Vincentz et al., 2008). 
 Hand1 expression marks trunk NCC-derived neurons within the 
sympathetic ganglia (Cserjesi et al., 1995; Firulli et al., 1998; Hollenberg et al., 
1995). Comparison of Hand1 expression with that of the Hand1-lineage shows 
little variation (Fig. 4J, K). Hand1Lacz/+ E18.5 embryos show robust β-gal staining 
within the sympathetic chain (Fig. 4J), and this expression persists in adults (data 
not shown). Hand1-lineage is consistent with this expression (Fig. 4K). 
Finally, we looked at the Hand1-lineage within the vagal/sacral NCC-
derived cells of the enteric nervous system and gut at E12.5 and 14.5 (Fig. 4L-N, 
P-R).  Hand1 expression was found in the smooth muscle component of the 
midgut and hindgut.  At E14.5, the Hand1-lineage robustly marks both the 
submucosa of the duodenum, a smooth muscle cell subpopulation surrounding 
the muscilaris externa, and the outer connective adventitia. The Hand1-lineage is 
absent from villus epithelium. Additionally, the Hand1-lineage is detected within 
the posterior vein and the bile duct, as well as the surrounding connective tissue. 
Comparison of the Hand1-lineage to the Wnt1-lineage at E14.5 indicates that the 
Hand1 lineage is excluded from the NCC components of the enteric nervous 
system but does mark lateral mesoderm structures of the gut (Fig. 4Q, S).  
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The Hand1-lineage shows varying contributions to the developing fore- and 
hindlimbs 
Hand1 is expressed, beginning at E11.5, within the anterior-ventral 
domain of the developing mouse limb and, by E13.5, is restricted to digit 1 
(Fernandez-Teran et al., 2003). Hand1 is also expressed within the lateral 
mesoderm medial to the forming limb buds. Compared to Hand2, limb expression 
Hand1 is greatly restricted; however, expression of these two related factors 
does partially overlap (Fernandez-Teran et al., 2003; Firulli et al., 2005).   
Forelimb expression of Hand1 at E9.5 and E10.5 appears in the lateral 
mesoderm underlying the forelimb bud (Fig. 5A,E). Lineage analysis marks this 
lateral mesoderm in addition to clonal cell populations within the limb bud (Fig. 
5B). At E10.5 the Hand1-lineage marks a subset of cells that contribute 
predominantly to the ventral side of the limb bud, indicating that Hand1-positive 
cells in the lateral mesoderm contribute to limb bud development in a pattern-
specific manner (Fig. 5F).  
 Meanwhile, hindlimb expression of Hand1 at E9.5 marks the both the 
lateral mesoderm and the ventral mesenchyme of the limb bud (Fig. 5C). The 
Hand1-lineage at E9.5 marks, in addition to the ventral and lateral mesoderm 
derived cells, a considerable subset of mesenchymal cells occupying the dorsal 
compartment of the limb bud (Fig. 5D).  At E10.5, Hand1 hindlimb expression 
becomes restricted to the lateral mesoderm, while we see a broad expansion of 
the Hand1-lineage throughout the hindlimb mesenchyme. This indicates that both 
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dorsal and ventral hindlimb mesenchyme receive an early and substantial 
contribution of Hand1-expressing cells. 
 Hand1 expression is considerably downregulated within the limb bud by 
E10.5. Whole mount analysis of Hand1LacZ at later stages confirms, as has been 
previously reported, a late domain of expression at E12.5 in both the fore- and 
hindlimbs (Fig. 5I,K) (Fernandez-Teran et al., 2003).  This expression of Hand1 is 
downregulated in the limb by E14.5 (Fig. 5M, N).  Lineage analyses at E12.5 and 
E14.5 confirm contribution of Hand1-expressing cells to the limbs with, as 
expected, comparatively more extensive staining in the hindlimb, (Fig. 5J, L, N, 
P). Importantly, these experiments indicate that there are two separate 
expression domains of Hand1 within the developing limb. First, there is an early 
expression domain, detectable during stylopod formation, largely within the 
lateral mesoderm and the ventral forelimb bud. Surprisingly, derivatives of these 
early Hand1-expressing cells contribute extensively to the limb bud 
mesenchyme. Second, there is a late expression domain of Hand1 that is crucial 
for digit formation during autopod maturation (Fernandez-Teran et al., 2003). 
Together, this data indicates that the expression and contribution of Hand1 
during limb formation is more dynamic than previously thought.  
The Hand1-lineage contributes to the extra embryonic mesoderm and 
trophoblasts during placental development  
 Hand1 null mice die between 8.5 and 9.5 due to defects in extra 
embryonic and vascular tissues (Firulli et al., 1998; Morikawa and Cserjesi, 2004; 
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Riley et al., 1998). Contributions of the Hand1-lineage to the placenta and 
associated vasculature were assessed at E9.5, and E14.5 (Fig. 6). As expected, 
at E9.5 the Hand1-lineage marks the chorion, allantois, yolk sac, and trophoblast 
giant cells (Fig. 6A-D), and is not observed within the decidua (Fig. 6A, C). At 
E14.5, after the specific layers of the placenta have formed, the Hand1-lineage 
contributes, in addition to yolk sac and chorion, to the amnion, both the 
endothelium and the smooth muscle of the umbilical vein, Wharton’s jelly, which 
surrounds and insulates the developing umbilical chord, the vitiline vessels, a 
heterogeneous cell population within the placental labyrinth and the trophoblasts 
with the anterior domain of the spongy layer (Fig. 6E-H). To identify these 
Hand1-lineage-postive cells within the labyrinth, immunohistochemistry was 
performed using eGFP, Flk1 and αSMA antibodies at E12.5 (Fig. 6I-P). A 
complete overlap of eGFP and Flk1 immunoreactivity is observed, suggesting 
that the Hand1-lineage marks the vascular endothelium, where as the 
complimentary pattern of αSMA suggests that smooth muscle within this domain 
derives from cells independent of Hand1-expression. Real-time Hand1 
expression is indistinguishable from Cre expression at these stages (data not 
shown). Taken together, these data show that cells which do express or which 
have expressed Hand1 compose nearly all trophoblasts and components of the 
extraemrbyonic vasculature as well as a significant portion of the labyrinth 
endothelium.  
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Hand1 marks vascular structures derived from lateral mesoderm  
At E9.5 and 10.5, real-time Hand1LacZ staining clearly shows lateral 
mesoderm-restricted expression (Fig. 7A-B). In contrast, Hand1-lineage analysis 
at these time points reveals cells migrating out of the lateral mesoderm between 
the somites (Fig. 7C-D). Close examination suggests that these cells are forming 
the vascular plexus of the intersomitic vessels. CD31 (PECAM) antibody staining 
confirms that these Hand1-lineage cells are vascular endothelium (Fig. 7C-F). 
Comparison between the Hand1, lineage and the Wnt1-Cre lineage confirms the 
Hand1 lineage marked vascular endothelium is derived from the lateral 
mesoderm and not the NCC lineage (Fig. 7G-H). No Hand1-linage contribution 
was observed rostral to the forelimb, indicating that the vascular progenitors of 
these vessels are independent of Hand1 expression (data not shown).  
To more precisely characterize Hand1 vascular contributions, we 
examined the Hand1-lineage within caudal sections of E9.5 day embryos (Fig. 8). 
Hand1-linage cells are readily detectable in the caudal endothelium of the dorsal 
aorta (Fig. 8B, D). Interestingly, at E14.5 the Flk1-positive endothelium of the 
distal dorsal aorta (Fig. 8G, K) is composed of a mix of both Hand1-lineage, 
detected by expression of eGFP (Fig. 8G, K), and non-lineage cells (Fig. 8H, L). 
Hand1-lineage cells are not observed within the endothelium of the proximal 
dorsal aorta (data not shown) but can be observed in small populations within the 
vessels that increase in number moving caudally from the forelimb. Interestingly, 
the Hand1-lineage also marks a small population of blood cells (Fig. 8D, L). It is 
likely that the extensive Hand1-expressing cells within extra embryonic structures 
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and the lateral mesoderm respectively contribute to blood islands within the yolk 
sac and, potentially, blood cells that populate the liver. Given that the Hand1-
lineage contributes to endothelium of both the intersomitic vessels and the dorsal 
aorta, we conclude that components of the caudal vasculature and some 
hematopoietic cells derive from Hand1-expressing progenitors. 
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Chapter Two  
Hand2 Deletion in the Hand1 Lineage 
 
Dynamic Expression of Hand factors during Heart Morphogenesis 
 E8.5 linage analysis of Hand1 reveals that the linear heart tube is not 
completely derived from Hand1-expressing cells.  To account for a temporal 
delay of Cre expression, we performed whole mount ISH for Hand1 at E7.5. 
Hand1 is detected throughout the extra embryonic mesoderm, chorion, and 
allantoic rudiment (Fig. 9A).  As the chorion is directly adjacent to the cardiac 
crescent (Fig. 9A,B white arrow), we performed a double label ISH for both 
Hand1 and the cardiac marker Mlc2a (Cai et al., 2003).  Results show that 
Hand1 does not overlap with Mlc2a heart expression at E7.5, suggesting that 
Hand1 expression initiates in cardiomyocytes subsequent to linear heat tube 
fusion (Fig. 9B).  
 To further delineate early Hand factor expression during cardiogenesis, 
we performed ISH for both Hand1 and Hand2 at E8.5 (Fig. 9C-F).  Whole mount 
ISH shows expression of Hand1 in the posterior heart tube while Hand2 is 
expressed throughout the entire cardiac field.  Sagital sections show Hand1 
expression restricted to myocardium of the early ventricular chamber and absent 
from the OFT.  Hand2 expression is throughout the endocardium and mesoderm 
of the SHF and OFT.  However, Hand2 is not detected in the myocardium of the 
ventricular chamber at E8.5 (Fig. 9F, red arrow). There is observable overlapping 
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expression within the SHF-derived OFT myocardium of the cuff and 
spatiotemporal overlap within the left ventricle FHF myocardium, suggesting that 
Hand factors may be functionally overlapping within these domains during 
cardiogenesis. Together, this indicates that Hand factors are dynamically 
regulated and lack significant overlapping expression profiles during early heart 
morphogenesis showing coexpression only within the SHF-derived myocardium 
of the cuff. 
Hand2 ablation within the Hand1-lineage results in novel phenotypes and 
embryonic lethality  
 Hand1-lineage analysis and Hand factor ISH reveals that Hand factors 
display largely complementary heart expression profiles, suggesting that both 
Hand1 and Hand2 exhibit unique functions during cardiogenesis.  To explore 
potential functional overlap, we ablate Hand2 within the Hand1 lineage (H2CKO) 
via intercross of Hand2fx (Morikawa and Cserjesi, 2008) and Hand1Cre mice.  
Hand1 and Hand2 ISH of H2CKO OFTs at E10.5 show successful ablation of 
Hand2 within the Hand1 domains of pharyngeal arch mesenchyme, lateral 
mesoderm contributing to the OFT myocardium, NCC-derived mesenchyme 
populating the OFT, and posterior lateral mesoderm  (Fig. 9G-L). 
H2CKO embryos were recovered at slightly below expected Mendellian 
ratios thru E12.5 (Fig. 10).  At E14.5, H2CKO embryos were recovered; however, 
roughly 50% of the H2CKOs collected were dead.  No viable H2CKOs were 
collected past E14.5.  H2CKOs displayed slight patterning defects along the A-P 
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axis of the limbs at E12.5 (data not shown), but otherwise appeared 
phenotypically normal.  Patterning of the heart, function of Hand1, and 
cardiomyocyte differentiation is normal (data not shown).  However, a multitude 
of defects are observed by E14.5 in H2CKOs. 
H2CKOs display pericardial hemorrhaging, anasarca, liver hypoplasia, 
syndactyly of the hindlimbs, and oligodactyly of the forelimbs (Fig. 10A-D, G-H).  
OFT septation defects, including Persistent Truncus Arteriosus (PTA) and 
Double Outlet Right Ventricle (DORV), are observed in all H2CKOs and suggest 
defects within cNCCs and/or SHF-derived myocardium (Fig. 10E-F,I-L). 
Hypertrabeculation/noncompaction and VSDs indicate H2CKOs suffer from 
severe cardiovascular defects that in isolation should result in neonatal lethality 
(Fig. 10M-P). 
Hand2ΔNCC die from a failure of the peripheral nervous system to 
synthesize norepinepherine prior to E12.5(Morikawa and Cserjesi, 2008).  Given 
that Hand1 is expressed within a subset of NCCs, it is possible that H2CKOs 
also die due to defects within the sympathetic nervous system.  Hand2ΔNCC 
embryos can be rescued postnatally with the administration of the β-adrenergic 
agonist isoproterenol (Morikawa and Cserjesi, 2008).  H2CKOs administered 
isoproterenol, in contrast to Hand2ΔNCC embryos, failed to survive till birth (Fig. 
11), indicating that sympathetic nervous system-related defects do not 
significantly contribute to H2CKO embryonic lethality. 
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Hand1 expression within the septum transversum marks the progenitors of 
the proepicardium  
 As Hand1-lineage cells are observed in the epicardium at E10.5, we 
examined Hand1 expression within the PE.  The PE is derived from the anterior 
surface of the septum transversum (ST) and gives rise to the epicardium (Watt et 
al., 2004).  ISH were conducted for both Hand1 and Tbx18, a marker of the PE, 
at E9.5 (Cai et al., 2008; Christoffels et al., 2009) (Fig. 11A-E).  Tbx18 is 
expressed throughout the PE but is not within the ST.  Hand1 expression is not 
detectable within the PE but is expressed robustly throughout the ST.  X-Gal 
staining of the Hand1LacZ confirms expression distinctly in the LV and the ST (Fig. 
11F).  X-Gal staining of the Hand1 lineage shows that Hand1-marked cells are 
dispersed throughout the ST and within the more proximal region marked by 
Tbx18-expressing cells (Fig. 11G-I).  Hand1-lineage cells are observed 
throughout the PE, consistent with a model where progenitor cells of the PE 
originate from the population of Hand1-expressing cells of the ST.   
Hand2 is expressed during epicardiogenesis and is required for function of 
the epicardium 
A surprising observation of the Hand1 lineage analyses is the link 
established between the Hand1-lineage and the forming epicardium.  As many 
epicardially deficient mouse models correlate with the time of death observed in 
H2CKOs, Hand2 ISH were performed at E9.5 and E10.5 to assess Hand2 
expression within the epicardial lineage (Fig. 12A,B,E,F) (Moore et al., 1999).  
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Indeed Hand2 expression is robust throughout the PE.  Hand2 is also expressed 
within epicardial cells at E10.5 as well as in isolated epicardial cells (arrow, Fig. 
12E, Fig. 13).  Hand2 expression is not detected in H2CKOs within the 
epicardium or the PE, confirming that the Hand1-positive cells within the early ST 
populates the PE and epicardium. Together this shows novel expression of 
Hand2 within the epicardium and a potential hierarchical relationship between 
Hand1 and Hand2 within establishing the epicardium. 
To determine if H2CKOs have epicardial defects, we performed 
histological analysis at E14.5 (Fig. 12I,J).  E14.5 Transverse sections revealed 
abnormal compaction and the absence of epicardium in conjunction with a lack of 
blood filled lumens running thru the epicardium, indicating epicardial phenotype 
for H2CKOs (Fig. 12I-J).  Analysis of epicardial markers at E10.5 (data not 
shown) and E12.5 ISH for Tcf21 suggests that the specification and formation of 
the early epicardium occurs normally (Fig. 12C,D). To determine whether the 
impact on epicardial development was a direct result of Hand2 function within the 
epicardium, we performed a conditional knockout of Hand2 within the WT1 
lineage utilizing the WT1ERT2Cre mouse line (Zhou et al.) (Fig. 12G,H,K,L).  At 
E13.5, Hand2fx/-;WT1-Cre mutant embryos display a poorly organized epicardium 
compared to WT embryos, and display a visible reduction in WT1-lineage 
marked cells(Fig. 12K-L), and appear to phenocopy the epicardial defects 
observed within H2CKOs.  These two independent epicardial Hand2 ablations 
indicate that Hand2 is not necessary for the initial establishment of the 
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epicardium but rather plays a role in maintenance, differentiation, and function of 
the maturing epicardium. 
Hand2 is required for the cardiac fibroblast fate and maintenance of 
coronary vasculature 
Since Hand2 loss-of-function leads to epicardial defects, we sought to 
further identify the role for Hand2 in the epicardium.  Platelet Derived Growth 
Factor (PDGF) receptors have been shown to play an essential role in cell fate 
and specification of the mature epicardium (Mellgren et al., 2008; Tallquist and 
Kazlauskas, 2004; Tallquist and Soriano, 2003).  ISH for PDGFRα at E12.5 
indicate a decrease in PDGFRα expression in the epicardium (Fig. 14A,B).  To 
look at the potential impact on epicardially-derived cardiac myofibroblasts, ISH 
for Periostin (Postn), a marker of the cardiac fibroblast cell fate, shows a marked 
decrease in Postn-positive cells invading the myocardium of E12.5 H2CKO 
mutant hearts (Fig. 14C-D) (Snider et al., 2008).  The decrease in Postn-positive 
cells within the myocardium suggests that Hand2 may play a role in determining 
epicardial cell fates that specify after epicardial cells undergo secondary EMT.   
Due to the observation that H2CKOs lacked blood filled lumen on the 
surface of the heart, we performed Flk1 immunohistochemistry at E12.5 to 
determine if there were any defects in coronary vessel formation (Shalaby et al., 
1995) (Fig. 14E-F).  Immunohistochemistry indicates an absence of Flk1-positive 
cells running thru the epicardium.  Counterstaining with Phalloidin shows that the 
epicardium is still intact, though absent of potential Flk1 lumens.  Previous 
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studies have shown the epicardium does not give rise to coronary vasculature 
and the Hand1-lineage does not contribute to this endothelial cell population 
(Barnes submitted) (Red-Horse et al., 2010).  Therefore, the severe 
abnormalities within the coronary vasculature of H2CKOs are likely due to non-
cell autonomous mechanisms that involve cell-cell communication between 
coronary endothelium and the contributing epicardial-derived smooth muscle  
To confirm that H2cKO coronary defects are secondary to epicardial 
defects, when conditional ablated using Hand1Cre and not resulting from Hand2 
ablation from myocardium or NCC (Fig. 14G,I,K), we generated H2cKOs Wt1Cre, 
and employed immunohistochemistry for Cre-lineage and Flk1 (Fig. 14H,J,L). 
WT1-lineage results confirm that the epicardium does not contribute to coronary 
vasculature in phenotypically wild type mice.  However, in WT1-genereatated 
H2cKOs, coronary lumens could not be detected thus confirming the non-cell 
autonomous affects of the Hand2-deficient epicardium.   
To further address the impaired function of H2CKO epicardium, we 
generated Epicardial Primary Cultures (EPCs) from wild type and H2CKOs and 
isolated total RNA for microarray expression comparison.  Gene ontology from 
our microarray analysis indicates significant differences between developmental 
and functional programs within the EPCs (Fig. 14M). Quantitative RTPCR on 
EPCs in WT and H2CKOs was performed to validate observed changes in gene 
expression levels observed in the microarray (Fig. 14N).  Quantitative RTPCR 
confirms expression of Hand2 within the epicardium as well as its ablation in the 
H2CKO EPCs. Interestingly results confirm that the ratio of PDGFRα:PDGFRβ is 
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greatly altered in H2cKO EPCs. Expression of PDGFRα is significantly reduced 
whereas PDGFRβ is significantly upregulated.  PDGFRβ-mediated signaling is 
associated in promoting the smooth muscle fate from the epicardium while a role 
for PDGFRα signaling in influencing epicardial cell fate is currently unclear 
(Mellgren et al., 2008). The observed decrease in the detection of Postn-positive 
myofibroblasts within the compact zone of the heart, suggests that PDGFRα may 
impact fibroblast differentiation from the epicardium progenitors. Together, this 
suggests that Hand2 directly impacts cell fate thru a potential PDGFR-dependent 
mechanism.   
Hand2 is required for proper Fn1 fibril assembly, organization, and cell 
adhesion required functions 
As H2cKO epicardial defects appear direct, we then looked at the impact 
upon epicardial mesothelium integrity. Fn1 has been shown to be downregulated 
in Hand2 mutants (Trinh et al., 2005).  Fn1 fibril assembly can regulate the 
organization and stability of ECM protein, is capable of promoting EMT and 
adhesion dependent growth, and defects in Fn1 underlie integrin mediated valve 
leaflet defects in the lymphatic system and is associated with cell signaling via 
integrins (Bazigou et al., 2009; Kadler et al., 2008; Leiss et al., 2008; Liao et al., 
2002; Sottile et al., 1998). Immunohistochemistry for Fn1 at E12.5 shows that 
Fn1 is expressed in the epicardium and is neatly organized around developing 
coronary vessels (Fig. 15A).  H2CKOs retained Fn1 in the epicardium, however it 
appears unorganized (Fig. 15B). To obtain a more detailed look at Fn1 
organization, we compared EPCs from wild type and H2cKOs (Fig. 15C-F). From 
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examination of the epicardium in culture, it is obvious that Fn1 fibril assembly is 
compromised. Compared to wild type immunostaining where an organized lattes 
of Fn fibrils is evident, H2cKO reveals a disorganized distribution Fn1 throughout 
the cell where deposition is uniform and sheet-like (Fig. 15C-F).  Fn1 dysfunction 
suggests a critical role for Hand2 in regulating the components of ECM assembly 
and directly impacting epicardium homeostasis during development. Alcian Blue 
staining was performed to verify an increase in ECM (Fig. 15G,H).  Indeed, there 
appears to be an increase in Alcian Blue staining, suggesting there is an 
increase in ECM deposition. 
Since Fn1 function is compromised in H2CKOs other extra cellular matrix 
components were analyzed. Gene ontology from microarray analysis to identify 
enriched biological processes indicates an enrichment in ECM based processes, 
such as cell-cell signaling, assembly, connective tissue development, and motility 
(Fig. 15I). Quantitative RTPCR on EPCs in WT and H2CKOs was done to look at 
alterations in Fn1 expression levels (Fig. 15J).  Fn1 expression was fond to be 
unchanged, as has been previously reported (Yin et al., 2010).   
In addition to its role as an ECM component, Fn1 promotes intracellular 
signaling via interactions with cell surface integrins (Ieda et al., 2009). To see if 
the observed Fn1 disorganization in H2cKOs potentially altered cell signaling, we 
looked at integrin expression by quantitative RTPCR (Fig. 15J). Indeed, 
expression of fibronectin receptor ITGA4 is significantly upregulated within the 
H2cKO cultures suggesting a feedback response resulting from diminished 
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signaling. In contrast, ITGA5 and ITGB1 that do not convey Fn1-mediated 
signaling show no significant changes in expression. 
Gene ontology data from microarray analysis also indicates enrichment for 
cell cycle regulation.  Loss-of-function of Hand2 has been implicated in the 
apoptosis of other cell types (Thomas et al., 1998).  Additionally, increased 
abnormal ECM organization and deposition have been implicated in cell death 
(Frisch and Francis, 1994).   Immunohistochemistry was performed for activated- 
Caspase3 and Phoso-Histone H3 at E12.5 to look at cell death and cell cycle in 
the epicardium of H2CKOs (Fig 15 K,L).   No change is observed in proliferation, 
suggesting that the process of epicardial EMT is not affected (Wu et al., 2010). 
Interestingly, we observe an increase in cell death within the epicardium of the 
H2CKOs.  This indicates that impaired ECM function in H2CKO may intricately 
be tied to not only proper function and integrity but also cell survival.  
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Chapter Three 
Discussion 
 bHLH proteins depend upon dimer formation to bind DNA and regulate 
gene expression; thus, defining where these factors are expressed is necessary 
to evaluate their mechanistic roles during organogenesis. The dynamic 
spatiotemporal expression of Twist family bHLH proteins renders an 
understanding of their mechanistic and functional roles as dictated by dimer 
partner choices a significant challenge. Although loss-of-function analyses in 
both systemic and conditional models have provided insights into the role of 
Hand1 in extra embryonic, cardiac, and NCC derived tissues, the expression 
data available is still limiting. 
 Here, we have created a Hand1 allele that permanently marks all Hand1-
expressing cells, enabling their developmental fates to be monitored. In some 
instances, such as in extra embryonic structures, observations of the Hand1-
lineage completely correlate with real-time expression; however, observations of 
lineage-marked cells clearly refine and expand real-time expression data, 
revealing novel potential domains of Hand1 function. This is exemplified in the 
developing myocardium by the near exclusive restriction of Hand1-marked cells 
to ventricular structures derived from the FHF. The Hand1-lineage marks the 
outer curvature of the left ventricle, is absent from the atria, and is not expressed 
at significant levels within the SHF-derived right ventricle, which robustly 
expresses the related factor Hand2. As Hand1 expression in the FHF 
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myocardium expands, Hand2 expression dominates within the SHF cells that are 
migrating into the heart from both atrial and venous poles. Hand1 is clearly 
expressed and specifically marks the SHF-derived myocardium within the 
myocardial cuff, a tight ring of myocardium in direct contact with the forming OFT. 
The Hand1-lineage does not contribute to the endocardium, whereas Hand2 is 
expressed within these cells. Therefore, Hand1 and Hand2 expression overlaps 
within FHF derived myocardium of the left ventricle beginning at E8.5 and within 
the SHF derived myocardial cuff at E9.5. Expression within other SHF-derived 
myocardium and endocardium is exclusively defined by Hand2. 
 The Hand1-lineage analyses potentially reveal a novel role for Hand1 in 
the formation of the epicardium. Comparison of Hand1LacZ/+ and Hand1eGFPCre/+ 
mice up to E9.5 shows no significant variation within the forming heart. By E10.5, 
the entire surface of the heart is composed of Hand1-lineage marked cells, 
whereas real time Hand1 expression is not observed. We also observed that 
coronary smooth muscle and cardiac fibroblasts, but not coronary endothelium, 
are derived from Hand1-expressing cells. Given that the epicardium gives rise to 
both cardiac fibroblasts and the smooth muscle of the coronaries, but not 
coronary endothelium, this supports the conclusion made by Red-Horse et al., 
that coronary endothelium is not a derivative of the epicardium, but comes from 
endothelial progenitors within the sinus venosae. Exploring the role Hand1 plays 
in defining epicardial progenitors will be an interesting and informative area to 
pursue. 
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 In addition to expression in the heart, Hand1-lineage contributes to the 
cardiac OFT, jaw, sympathetic nervous system and lateral mesodermal 
derivatives of the gut. Within the OFT, Hand1-lineage analysis suggests that the 
majority of cNCC within the OFT, at some point in their emigration, expressed 
Hand1; however, real-time expression at E10.5 shows that only a subset 
(approximately 50%; (Vincentz et al., 2008) actively express Hand1 transcript. 
These cNCC are interesting in that they coexpress Twist1 and Hand2, and 
although deletion of Hand1 in the NCC via Wnt1-Cre is reported to show no 
obvious OFT phenotypes (Barbosa et al., 2007), the Hand1 and Hand2 real-time 
expressing cells are observed to selectively show defective cell adhesion on the 
Twist1 null background (Vincentz et al., 2008). Given that gene dosage 
relationships between these potential dimer partners are evident, looking at more 
compound relationships between these factors using the Hand1 eGFP-Cre driver 
could be informative. 
 In the sympathetic ganglia, Hand1 expression is observed as early as 
E11.5. Hand2 expression precedes this upregulation. Wnt1-Cre mediated Hand2 
deletion results in a loss of Hand1 expression (Morikawa et al., 2007). Hand1 
expression within the sympathetic ganglia persists into adulthood and we 
observe no significant differences between real-time and Hand1-lineage 
expression patterns. Similarly Hand1-lineage analysis of the enteric nervous 
system does not show deviation from that of real-time Hand1 expression. 
 Within the cranial NCC, Hand1, in conjunction with dosage modifiers such 
as Hand2, impairs growth of the distal midline mesenchyme (Barbosa et al., 
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2007). Real-time Hand1 expression marks the midline of the developing 
mandible and the midline of the tongue. The Hand1-lineage clearly marks the 
midline mesenchyme of the frontal processes of the face throughout all Meckel’s 
cartilage derivatives.  Additionally, the Hand1-lineage appears to contribute to a 
more extensive domain in the midline region of the tongue. This suggests that 
either Hand1 expression becomes restricted during the differentiation process of 
the midline cranial neural crest cells or that the Hand1-lineage migrates outward 
from the site of active Hand1 expression in the midline cranial neural crest. 
 Ectopic expression of Hand factors within the limb results in preaxial 
polydactyly (Fernandez-Teran et al., 2000; McFadden et al., 2002 Fernandez-
Teran, 2003). Mechanistically, this phenotype is also a consequence of 
Hand/Twist gene dosage, where functional antagonism between Twist1 and 
Hand proteins mediated by dimer partner choice causes a variety of limb 
abnormalities (Firulli et al., 2005; Firulli et al., 2007). Real-time expression of 
Hand1 within the mouse limb is restricted to the anterior-ventral area of 
mesoderm at mid-level in the proximo-distal axis (Fernandez-Teran et al., 2003). 
In chick, this expression is accompanied by expression within the ventral lateral 
mesoderm of the forming limbs, but this domain was not detected in the mouse. 
Interestingly, Hand1-lineage analysis defines forelimb vs. hindlimb differences. 
Forelimb Hand1-lineage expression appears to mirror real-time expression, with 
the exception that the increased sensitivity of the R26R reporter reveals Hand1-
activty within the ventral mesoderm of the forming forelimb. The Hand1 forelimb 
lineage experiment reveals the early contributions of Hand1 expressing lateral 
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mesoderm to help establish dorso-ventral patterning (Johnson and Tabin, 1997). 
Molecularly, dorso-ventral patterning is established as an essential modular 
cascade within limb patterning and hobbling of this cascade models clinical limb 
defects (Ahn et al., 2001; Chen and Johnson, 2002; Chen et al., 1998; 
Grieshammer et al., 1996). Hindlimb contributions appear much more extensive 
than those revealed by real-time analyses and likely reflect the lateral 
mesodermal origin of the hindlimb mesenchyme. Although Hand1 function within 
the limbs is not well established, especially when compared to its putative dimer 
partners Hand2 and Twist, the differential activity of this Cre allele could help 
define its role in limb morphogenesis. 
 The last and perhaps most important role for Hand1 is its functions in 
extra embryonic tissues and its role in the specification and differentiation of 
trophoblast giant cells (Firulli et al., 1998; Morikawa and Cserjesi, 2004; Riley et 
al., 1998). Hand1 is persistently expressed in these extra embryonic tissues and 
trophoblasts cells and thus the Hand1-lineage does not add any additional 
insight. This expression raises the largest caveat with this Cre-driver in that, if 
extra embryonic expression is encountered, this Cre driver line would not be 
optimal for use in looking at gene ablation in embryonic structures. That being 
said, if potential targets for conditional deletion within the embryo are expressed 
in primary myocardium, post-migratory neural crest, lateral mesoderm and or 
hindlimb mesenchyme, use of this reagent could prove useful in dissecting 
mechanism via the conditional loss-of-function approach. 
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Together, the lineage and the conditional knock out data reveals a novel 
function for Hand factors in epicardiogenesis. Using Hand1-lineage data from our 
targeted Cre knockin, we present a model where transient expression of Hand1 
within the ST marks cells that go on to populate the PE and subsequently 
epicardium and its derivates. Directly downstream of Hand1, is the upregulation 
of Hand2 within the PE, which when ablated results in significant epicardial 
lineage defects that result in persistent expression of WT1 within migrating 
epicardial cells post secondary EMT, an impairment fibroblast differentiation, 
abnormal Fn1 deposition and organization associated with altered signaling, and 
an increased cell death. Collectively this results in poor functional integrity of the 
epicardium leading to a decline in epicardial function and a failure to form a 
patent coronary vasculature. The lack of epicardial function is likely the cause of 
death correlating well with other mouse models that show coronary 
malformations (Moore et al., 1999).  
Fn1 is a multifunctional protein helping to establish cytoskeletal 
organization, motility, and cell signaling pathways involved in proliferation and 
growth. As epicardial cells must migrate, alter morphology, and ultimately 
differentiate into functional cell type, the epicardial phenotypes observed in 
H2CKOs mechanistically are all dependent on Fn1 function.  Fn1 and ITGA4, a 
Fn1-specific receptor expressed within the epicardium, have been implicated in 
phenotypes associated with similar mesodermal, epicardial, and cardiovascular 
decline (George et al., 1997; George et al., 1993; Georges-Labouesse et al., 
1996; Yang et al., 1995). Additionally, alterations in Fn1 deposition are 
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associated with an increase in fibrosis and cell death (Tomita et al., 2007), 
phenotypes, which are observed in the H2CKO epicardium. Interestingly the 
functional regulation of Fn1 by Hand2 is clearly indirect in that mRNA and overall 
levels of FN1 protein not significantly altered in H2cKO epicardium. This 
suggests that additional ECM proteins, which are Hand2-dependent directly, 
influence Fn1 organization and deposition. Hand2 has been previously 
associated in regulating Fn1 deposition and has more recently been revealed to 
influence ECM deposition during lateral mesoderm remodeling prior to 
midgestation in zebrafish (Trinh et al., 2005).  Our data is completely consistent 
with these observations indicating that this functional role is not only 
evolutionarily conserved but also critical for maturation of epicardial derived cell 
types that clearly influence both myocardium and coronary endothelium non-cell 
autonomously. 
We observed no Hand1-lineage endothelial cells contributing to the 
coronary vessels within wild type or H2cKO mice. The origin of the coronary 
vessels endothelium is currently understood to be the sinus venosus (Red-Horse 
et al., 2010), and it is presumed that a functional  epicardium is required for 
establishing and maintaining the patency of the coronary vessels. H2CKOs 
appear to have lineage specific defects that impact both fibroblast and smooth 
muscle cell fates of the epicardium post secondary EMT. Close examination of 
Hand1-marked epicardium does not indicate the presence of Hand1-lineage 
independent cells (Barnes Submitted); moreover, Hand2 ISH similarly marks the 
entire epicardium suggesting that Hand2 is not enriched within a specific 
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epicardial lineage. Previous work establishes a relationship for PDGFRs to 
govern specific lineage subsets during epicardial development (Mellgren et al., 
2008; Tallquist and Kazlauskas, 2004).  PDGFRα is downregulated within 
H2CKO epicardium.  Although a role for PDGFRα  has not been clarified within 
the epicardium, it has been shown to be essential in other EMT derived cell 
populations (Tallquist and Soriano, 2003).  Interestingly, PDGFRβ  is reciprocally 
upregulated within H2CKO epicardium. This change in ratio between these 
related receptors could simply be the result simple compensation of PDGFRβ for 
the decreased expression of PDGFRα; however, PDGFRβ function has been 
directly associated with driving smooth muscle cell fates from epicardial derived 
cell populations (Mellgren et al., 2008). Given epicardium gives rise to both 
fibroblast and coronary smooth muscle and we observe a reduction in fibroblast 
invading the myocardium (Fig. 6), this may indicate an essential role for PDGFRα 
  in governing the fibroblast fate (Richarte et al., 2007) and that modulating the 
ratio of PDGFRs that govern these divergent cell programs is Hand2-dependent 
developmental program. 
In addition to the phenotypes observed within the epicardial lineage, 
Hand2 defects are observed within the cardiac OFT. Wnt1-Cre NCC specific 
deletion of Hand2  reports arch defects, DORV, and associated VSDs (Holler et 
al., 2010). Considering that Hand2 ablation within the Hand1-epxressing cNCCs 
is temporally delayed and spatially more restricted then Hand2ΔNCC, the high 
penetrance of a more severe NCC-dependent PTA phenotype suggests that 
genetic and possibly functional interactions between Hand1 and Hand2 are 
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critical for OFT septation as H2CKOs generated using Hand1Cre are 
heterozygous null for Hand1. These data are supported by the previously 
identified genetic interactions between Hand1 and Hand2 within the left 
ventricular myocardium and the pharyngeal arches (Barbosa et al., 2007; 
McFadden et al., 2000) and is directly supported with established dimer 
regulation mechanisms that govern the dimer formation and biological output of 
Twist-family bHLH factors. Indeed dysregulation of Twist1 dimerization is 
causative of the autosomal dominant human disease Saethre Chotzen Syndrome 
and directly reflects molecular antagonism between Twist1 and Hand2 (Firulli et 
al., 2005; Jabs, 2004). The idea that Hand1 and Hand2 dimer choice is 
modulated by phosphoregulation and/or gene dosage/expression dictates a well-
supported biological model for Hand factor function in OFT morphogenesis and 
experiments to investigate the latter mechanism are currently underway.  
 A final observation is that Hand1 and Hand2 display very unique 
expression domains within the developing murine heart. Hand1 is largely 
restricted to the cells of PHF that make up the left ventricle and expression within 
the SHF is restricted to the myocardial cuff that makes direct contact with the 
NCC-derived OFT (Barnes, submitted).  It is this SHF domain where co-
expression with Hand2 is visibly persistent. Hand1 expression and lineage is 
detectable at E8.5 within the forming left ventricle and it is at this stage, during 
the onset of cardiac looping. Although we observe a thin compact zone and 
hypertrabeculation within H2CKOs, the cell autonomy of these defects cannot be 
deduced. Hand2 ablation using cardiac a specific Cre results in early embryonic 
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death exhibiting a similar phenotype to the systemic Hand2 knockouts 
suggesting that these defects are SHF-dependent (Morikawa and Cserjesi, 
2008). Although Hand1Cre mice allow insight into a possible role for Hand2 in the 
PFH myocardium, isolation of the PHF enhancer or use of a PHF-specific Cre will 
be required to address this directly. Collectively, these studies demonstrate, that 
in addition to the established roles of Hand2 within the cNCC and myocardium, 
Hand2 plays a novel and critical role in the function and differentiation of 
epicardium, by modulating cell signaling mechanisms that  dictate epicardial cell 
fates as well as  ECM organization that  is  required for proper formation and 
function of the heart.  
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Overview & Future Aims 
 The Hand1 lineage has provided substantial descriptive and mechanistic 
insight into Hand factor function.  Analyzing the Hand1 lineage was a daunting 
task given the dynamic spatial and temporal expression domain.  However, the 
lineage analysis proved to be insightful into highly specific contributions to 
different developmental lineages.  This descriptive data suggests further insight 
into the neccessity and function of Hand1 throughout development.  Additionally, 
given the dynamics and promiscuity of Hand factor dimer pairing, the Hand1 
lineage analysis focuses our insight into Hand protein distribution and dimer 
regulation. 
 Descriptive analysis of the Hand1 lineage led to spatial clarification for 
Hand1 in several lineages.  Strikingly, the Hand1 lineage contributed to vascular 
endothelium in multiple developmental spatial systems throughout the embryo.  
Hand1 has not been documented as previously being expressed in vascular 
endothelium.  Vascular endothelium of the descending dorsal aorta raises 
questions about lateral mesodermal precursors in which Hand1 is actively 
expressed.  Additionally, lineage analysis for Hand1 in the placental labyrinth 
vascular endothelium proposes a novel role for Hand1 during labyrinth 
development and possibly creating a more complex role for Hand1 during 
placental development.  The analysis of limb lineage data reveals a surprising 
early contribution of Hand1-positive cells to the limb buds in addition to a specific 
localization within the A-P axis of the developing forelimb.  Lineage analysis also 
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illustrates an expansion in the contribution for Hand1 within the mesothelial cell 
population, given the insight derived from epicardial cell derivatives.  NCC 
analysis revealed a striking refinement in postmigratory NCC for the Hand1 
lineage and suggests highly specific function for Hand1 in this population.  
Finally, the Hand1 lineage allowed a conclusive examination of Hand1 function 
during left ventricular development and provides much needed discussion for this 
pivotoal chamber and tissue specific transcription factor since the onset of heart 
lineage data reconstructed our models for cardiogenesis. 
 The result of the Hand1 lineage analysis raises many questions that may 
be addressed in future studies.  Conditional ablation studies using vascular 
specific Cre Recombinase mouse lines may offer insight into the functional roles 
for Hand1 in both dorsal aorta and placental labyrinth function.  Cell surface 
marker profiling of Hand1-positive erythrocytes via FACS analysis and colony 
forming unit experiments may lead to exciting subset profile that may implicate 
the Hand1-lineage in endothelial stem cell development.  The derivatives of 
Hand1-expressing cells in the septum transversum may lead to multiple projects 
in the near future.  First, a loss-of-function experiment for Hand1 may implicate it 
mechanistically in defining mesothelial precursors.  Second, functional implication 
may be further enhanced by the identification of a novel enhancer element.  
Finally, a transgenic Cre Recombinase mouse line following the potential 
discovery of a septum transversum specific enhancer would be a highly sought 
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after  tool by the scientific community due to the lack of a true epicardial cre line 
to this point. 
 Conditional ablation experiments utilizing the Hand1Cre to ablate Hand2 
have led to substantial insight into Hand factors dynamics and functional overlap 
during development.  The lineage assessment of Hand1 led to a rigorous 
examination of Hand factor expression during cardiogenesis.  This resulted in 
redefining Hand factor expression as more distinct than previously reported.  
Thought the factors are complex in terms of function, these experiments confirm 
they do not appear to be functionally redundant using a loss of function model.  
While Hand2 has been implicated primarily as a NCC and mesodermal 
transcription factor, the results from this study reveals unique insight for Hand2 in 
mesothelial cardiac populations while expanding mechanistic insight for Hand2 in 
cell survival, matrix organization, and cell fate selection.   
 These loss of function experiments suggest future experimental studies in 
the near future.  Although the study entails several conditional Cre Recombinase 
mouse lines, the conditional ablation of Hand2 in the epicardium has been 
hampered due to difficulties in finding Cre mouse lines that are truly restricted to 
epicardial mesothelium.  Either development of other more specific epicardial Cre 
drivers or the development of a Hand1 septum transversum cre line would enable 
a more tailored examination of Hand2 epicardial deletion.  Given the specific role 
for Hand1 in mesothelial and vascular labyrinth placental populations, and given 
the close temporal expression between Hand factors, it might prove useful to 
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scrutinize placental expression of Hand2 and identify suitable Cre Recombinase 
mouse lines that would test an expanded role for Hand2 during placental 
development.  Insight into modulation of epicardial cell fate effectors was novel to 
the Hand2 literature.  Unfortunately, the tools in these studies were insufficient to 
thoroughly assay the impact of Hand2 on cell fate.  Utilizing Hand2 expression 
and siRNA adenovirus on ES cells bearing transgenic eGFP reporters for Thy1, 
Myh11, Wt1 may yield further insight into epicardial fate.  The enlightenment of 
Hand2 expression in cardiovascular lineages raises the ideas to pursue a more 
thorough cardiac chamber study.  Generating a Hand2LacZ allele would be an 
essential tool for expression analysis.  Additionally, utilizing SHF Cre mouse lines 
in conjunction with utilizing Hand2 expression and siRNA adenovirusʼ on ES cells 
bearing transgenic eGFP reporters would enhance our understand of the function 
of this essential and highly evolutionarily conserved bHLH protein. 
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Chapter Four 
Figures 
 
Figure 1: Generation and validation of the Hand1eGFPCre mouse line. A) The 
Hand1 locus is shown at the top with non-coding and coding regions indicated by 
the white and numbered-black boxes, respectively. The targeting vector is shown 
below with the dotted lines indicating regions of sequence identity between the 
targeting arms. The targeting strategy introduced an eGFPCre cassette into the 
5’ untranslated region of Hand1, followed by an FRT-flanked PGK-neo.  
Homologous recombination resulted in deletion of the first exon of Hand1 and 
insertion of the eGFPCre gene under control of the endogenous promoter. 
Following germline transmission of the mutation, the PGK-neo was deleted by 
subsequent mating with the FLPeR mouse line. B) Southern blot of 
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Hand1eGFPCre+Neo/+ offspring using an external probe to detect the targeted allele 
and C) using an internal probe to confirm the absence of transgenic incorporation 
of the targeting construct. D) Southern blot of Hand1eGFPCreΔNeo/+ offspring 
following Flp Recombinase mediated deletion of the PGK-neo.  (E, F)  RNA in 
situ hybridization on E13.5 Hand1eGFPCreΔNeo/+ embryos shows identical tissue-
specific Hand1 and eGFPCre expression. 
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Figure 2:  The Hand1-Lineage contributes to a subset of the first heart field 
and epicardium. DIG-labeled whole-mount (A, B) and transverse section (G, H) 
in situ hybridization for Hand1 on wild-type embryos at E9.5 and E10.5.  LacZ 
staining of the Hand1LacZ (C, D, I, J) and Hand1eGFPCre lineage (E, F, K, L). ep, 
epicardium; lm, lateral mesoderm; lv, left ventricle; rv, right ventricle. 
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Figure 3: Analysis of the adult Hand1 lineage shows restriction to specific 
cardiovascular lineage subsets. LacZ staining of Hand1-lineage cryosections 
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(A, B). E13.5 immunohistochemistry for Flk1 (red; D, G) and the Hand1-lineage 
(green; C, F).  Overlay of Flk1 and the Hand1-lineage (E, H). E13.5 
immunohistochemistry for the Hand1-lineage (green; I) counterstained with DAPI 
(blue; J).  Overlay for DAPI and the Hand1-lineage (K).  at, atria; da, dorsal aorta; 
ep, epicardium; lv, left ventricle; pt, pulmonary trunk; rv, right ventricle.   
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Figure 4: The Hand1-lineage marks discrete neural crest cell populations. 
Whole-mount LacZ staining of Hand1LacZ (A,J) and the Hand1-lineage (K). 
Transverse sections of whole mount LacZ stained Hand1LacZ (F) and Hand1-
lineage (G) embryos.  LacZ staining of Hand1LacZ (B, C, E, F, L, M, P, and Q), 
Hand1-lineage (D, G, N, and R), and Wnt1-lineage (O,S) cryosections. en, 
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enteric; hg, hindgut; ma, mandible; mc, meckel’s cartilage; mg, midgut; mp, 
mandibular process; oft, outflow tract; pv, posterior vein; sg, sympathetic ganglia; 
t, tongue. 
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Figure 5: Analysis of the Hand1 limb lineage.  LacZ Staining of Hand1LacZ and 
the Hand1 lineage at E9.5 (A-D), E10.5 (E-H), E12.5 (I-L), and E14.5 (M-P).  
Transverse sections of LacZ stained embryos showing fore and hind limbs (A-H).  
Whole-mount LacZ staining (I-P).  d, dorsal; lm, lateral mesoderm; v, ventral. 
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Figure 6:  The Hand1 lineage contributes to the EEM and Trophoblasts 
during placental development. LacZ staining of Hand1-lineage cryosections 
(A-H).  Immunohistochemistry for the Hand1-lineage (green; I, J, M, N), Flk1 (red; 
K), αSM-Actin (red; O).  Overlay for the Hand1 lineage, Flk1, and DAPI (blue; L).  
Overlay for the Hand1 lineage, and αSM-Actin, DAPI (blue; P). al, allantois; am, 
amnion; ch, chorion; de, decidua; ep, ectoplacental plate; gc, giant cell; lb, 
labyrinth; sp spongiotrophoblast; uc, umbilical chord; uv, umbilical vessels; ys, 
yolk sack; wj, Wharton’s jelly.  
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Figure 7: Lateral mesodermal derivatives of the Hand1 lineage gives rise to 
intussuceptive microvascular growth. Whole-mount LacZ staining of the 
Hand1LacZ (A, B), the Hand1-lineage (C, D), and the Wnt1-lineage (G, H).  Whole-
mount antibody staining for CD31 (E, F).   
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Figure 8:  Lateral mesodermal derivatives of the Hand1 lineage give rise to 
endothelial progenitors of the dorsal aorta.  Whole-mount LacZ staining of the 
Hand1-lineage (A, C). Transverse sections of whole mount LacZ stained Hand1-
lineage embryos (B, D).  Immunohistochemistry for the Hand1-lineage (green; F, 
J), Flk1 (red; G, K), and DAPI nuclear staining (blue; E, I). Overlay for the Hand1-
lineage, Flk1, and DAPI (H, L).  cv, cardinal vein; da, dorsal aorta; eem, extra 
embryonic mesoderm; lm, lateral mesoderm; sg, sympathetic ganglia. 
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Figure 9: Inactivation of Hand2 within the Hand1 lineage.  Single and double-
labeled Mlc2a and Hand1 whole mount RNA ISH of E7.5 embryos show that 
Hand1 is not expressed within the cardiac crescent (white arrow) but is 
expressed within overlying extra embryonic mesoderm, allantoic rudiment, and 
the chorion (A,B).  Hand1 and Hand2 whole mount RNA ISH of E8.5 embryos 
shows complimentary expression of Hand factors early during cardiac 
development (C-F).  Hand2 expression is confined to the SHF and endocardium 
of the developing ventricular chamber (black arrow).  Hand2 RNA ISH on 
transverse sections at E10.5 shows the deletion of Hand2 within the Hand1 
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lineage (G-L).  Deletion of Hand2 is restricted to a distinct subset of NCC, 
cardiovascular, and lateral mesoderm derivatives where Hand factors are 
coexpressed. cc, cardiac crescent; eem, extra embryonic mesoderm; hbp, 
hepatic/biliary primordia; ht, heart tube; lm, lateral mesoderm; mg, midgut; oft, 
outflow tract; pa, pharyngeal arch; v, ventricle. 
 79 
 
 
Figure 10:  Conditional deletion of Hand2 within the Hand1 lineage results 
in extensive embryonic and cardiovascular defects. Whole mount (A-D, G, H) 
and histological (E, F, I-P) analysis of phenotypes in H2CKO embryos at E14.5.  
Mutant mice display pericardial hemorrhaging (A) and extensive edema, termed 
anasarca (B).  Compared to WT mice (C), mutant mice have hypoplastic livers 
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with extensive hemorrhaging (D).  Histological examination of embryonic hearts 
reveal extensive cardiovascular phenotypes.  H2CKOs have both DORV and 
PTA’s OFT defects (E-N).  In the ventricles, H2CKOs exhibit full penetration of 
VSD’s.  Closer examination shows abnormal trabeculae and the absence of 
compaction in the compact zone (O,P).  ao, dorsa aorta; cz, compact zone; od, 
oligodactyly; pt, pulmonary trunk; pta, persistent truncus arteriousus; sd, 
syndactyly; tr, trabeculae.  
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Figure 11:  The Hand1 lineage gives rise to epicardial progenitors. E9.5 
cartoon illustrating Hand1 expression (blue) and showing planes of section in B-E 
(A).  Hand1 and Tbx18 section ISH of E9.5 embryos on adjacent sections 
through the septum transversum and the proepicardium (B-E).   Analysis shows 
that Hand1 expression is not detected within the proepicardium but is expressed 
in the septum transversum.  LacZ staining of both the Hand1LacZ (F) and R26R 
activation via Hand1eGFPCre (G-I) shows Hand1-lineage cells within the septum 
transversum and in the proepicardium, confirming that Hand1 is expressed in 
proepicardial progenitors. lv, left ventricle; pe, proepicardium; st, septum 
transversum. 
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Figure 12: Loss of Hand2 results in a lethal epicardial phenotype.  RNA ISH 
at E9.5 (A-B) shows Hand2 expression throughout the proepicardial organ and in 
the epicardium (red arrow) at E10.5 (E-F).  Consequently, Hand2 expression is 
ablated in the presumptive epicardial mesothelium in H2CKOs.  Histological 
examination at E14.5 shows a lack of epicardium and compaction abnormalities 
in H2CKOs (I-J).  RNA ISH for Tcf21 at E12.5 shows normal establishment of the 
epicardium (C-D).  LacZ staining and conditional deletion of Hand2 within the 
Wt1 lineage at E13.5 recapitulates epicardial defects and time of death observed 
in H2CKOs via Hand1eGFPCRE (G-L).  pe, proepicardium. 
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Figure 13: Hand2 is expressed in epicardial cultures. RT-PCR on 4-day 
epicardial explants indicates Hand2 is expressed in epicardial cultures (A).  
Imunocytochemistry indicates an enrichment for epicardial cells in the explant 
cultures (B-D). 
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Figure 14: Fibroblast lineage and secondary coronary defects in H2CKOs. 
RNA ISH  at E12.5 for PDGFRα  and Postn (A-D).  A decrease in fibroblasts is 
observed in the compact zone of H2CKOs. Immunohistochemistry for Flk1 
(green) and F actin (red) at E12.5 (E-F).  A decrease in coronary vasculature is 
observed in H2CKOs. Immunohistochemistry at E13.5 for the Hand1 lineage (G) 
and the Wt1 lineage (H) showing staining specificity in phenotypically wild-type 
mice.  E13.5 Hand1 lineage (G,I), H2CKO (K), Wt1 lineage (H,J), and Wt1 
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conditional knockouts of Hand2 (L).  Immunohistochemistry for Flk1 (red) and 
Lineage (green) confirms coronary vessels are not derived from the epicardium, 
but Hand2 conditional deletion in the epicardium leads to epicardial defects and 
absent coronary vessels.  Gene ontology analysis microarray showing affected 
pathways in H2CKO isolated epicardium (M).  qRTPCR on WT (blue bar) and 
H2CKO (black bar) isolated epicardium; n=4 (N).  Asterisks indicate statistical 
significance: *p < 0.05; **p <0.01. 
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Figure 15:  Abnormal Fn1 matrix assembly and function results in matrix 
related defects and impaired epicardial development.  Immunohistochemistry 
at E12.5 for Fn1 (green) and F-actin (red) showing Fn1 expression in the 
epicardium and displaying absent coronary vessels (A,B).  Isolated epicardial 
cells show an aberration from normal Fn1 localization, where WT epicardial cells 
distribute Fn1 in a series of well formed lattices, Fn1 appears to be distributed 
uniformly throughout the cells, further suggesting migratory defects in H2CKO 
epicardial cells (C-F). An increase in alcian blue staining the epicardium indicates 
increased ECM (G,H). Gene ontology analysis microarray showing affected 
pathways in H2CKO isolated epicardium (I).  qRTPCR on WT (blue bar) and 
H2CKO (black bar) isolated epicardium; n=4 (J).  Cell proliferation (K) and Cell 
apoptosis (L) on WT and H2CKO embryos at E12.5; n=3.  Asterisks indicate 
statistical significance: *p < 0.05; **p <0.01.  
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Chapter Five  
Methods 
 
Targeting Hand1 and Generation of Mice   
To construct the targeting vector, a 3.4Kb EGFPCre cassette (kindly 
provided by Dr. Simon J. Conway) was isolated with a XhoI/HindIII digest and 
ligated into pBluescript SK+.   A 3.0Kb BstEII fragment, cloned into pBluescript 
SK(+), upstream from the Hand1 translational initiation codon was isolated with a 
XhoI digest and  ligated 5’ of the EGFPCre cassette.  A 1.75Kb Frt-flanked 
neomycin cassette was isolated from ploxFlpneo (provided by Thomas Saunders 
U. Michigan) with an EcoRI/NotI digest and ligated 3’ of the EGFPCre cassette.  
A 1.6Kb SalI/HindIII fragment, cloned into pBluescript SK(+), that extended from 
within the first intron of the gene into the second exon was isolated with a NotI 
digest and cloned 3’ of the neomycin cassette.  The targeting vector was 
linearized with XhoI, prior to electroporation into CCE 916 wildtype ES cells, and 
plated onto G418-resistant STO feeder layers.  Following positive selection with 
G418, individual ES colonies were isolated and analyzed by Southern blot for 
homologous recombination at the Hand1 locus, as previously described(Firulli et 
al., 1998).  Homologous recombination was observed at a frequency of 1:4 in the 
150 ES cell clones analyzed.  Four independent clones were injected into 
blastocysts obtained from C57/B6 mice, which were subsequently implanted into 
pseudopregnant Swiss foster females.  Chimeras that were obtained transmitted 
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the Hand1 mutation through the germline and the resulting offspring were 
intercrossed with homozygous R26Fki (FLPeR) mice on a pure 129/SvJaeSor 
genetic background to permanently delete the neomycin cassette.   Offspring 
were then intercrossed to remove the R26Fki  allele.   
Genotyping 
ES cell DNA, as well as tail genomic DNA from Hand1EGFPCreΔNeo/+ mice, 
were analyzed for the Hand1 mutation by Southern-blot analysis(Firulli et al., 
1998).  Insertion of the EGFPCre and neo genes into the Hand1 locus introduced 
an EcoRI site that could be used to distinguish the wild-type and targeted alleles, 
which yielded 10.0Kb and 4.0Kb fragments, respectively, following Southern 
analysis of EcoRI-digested DNA and hybridization with a labeled BssHII-XhoI 
probe from the region 3’ of the targeted mutation.  Following removal of the neo 
gene, the 4.0Kb fragment shifted to a 2.25Kb fragment.  Since the targeting 
construct did not contain a negative selection gene, an 861bp NcoI fragment 
from the EGFPCre cassette was labeled and hybridized to EcoRI-digested DNA, 
yielding a 10.0Kb band.  Ectopic bands were not detected.   
ROSA26R homozygous mice were genotyped using a probe located 5’ of 
the STOP Flox (provided by Dr. Phillippe Soriano).  Southern analysis of EcoRV-
digested DNA was hybridized with labeled probe and yielded a 3.8Kb band. 
 The Wnt1-Cre transgene was detected in genomic DNA isolated from tail 
samples using the primers 5’–TCGATGCAACGAGTGATGAG–3’ and 5’–
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TTCGGCTATACGTAACAGGG–3’, which recognize the sequence encoding Cre, 
and generate a ~470bp amplicon. 
 The Hand2flox/flox mice and Wt1ERT2Cre mice (provided by William Pu 
Harvard) were genotyped as previously described (Morikawa and Cserjesi, 2008; 
Zhou et al., 2008).   
Mating Schemes and Histological Preparations 
Hand1EGFPCreΔNeo/+, WT1ERT2Cre and Wnt-Cre males were crossed to 
ROSA26R reporter mice(Soriano, 1999). Hand1EGFPCreΔNeo/+; Hand2+/- and 
WT1ERT2Cre; Hand2+/- mice were crossed to Hand2flox/flox; ROSA26R reporter mice 
(LacZ or eYFP) to generate conditional null Hand2 embryos.   
X-gal staining, and histological preparations were done as previously 
described for paraffin embedded sections and whole mounts(Vincentz et al., 
2008).  For E15.5 and adult heart, embryos/tissues were dissected in PBS and 
fixed in a 1:1 mixture of 4% paraformaldehyde (PFA) in phospho-buffered saline 
(PBS) and 1X PBS for 5 minutes at 4OC.  Samples were then moved to 30% 
sucrose in 1X PBS overnight at 4OC.  Samples were then cryoprotected and 
stored at -80OC.  Samples were sectioned at 10-20mm and washed for 5 minutes 
in 1X PBS.  Sections were then post-fixed in 0.5% PFA for 2 minutes, rinsed in 
1X PBS then washed in 1X PBS for 10 minutes.  Slides were then incubated with 
X-gal solution in the dark at 37OC overnight.  Slides were rinsed in 1X PBS and 
then post-fixed in 4% PFA for 20 minutes and then were washed three times in 
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1X PBS at room temperature for 5 minutes each.  Slides were counterstained 
with Nuclear Fast Red.  
Section RNA In Situ Hybridization 
 Section in situ hybridization was performed essentially as previously 
described(Vincentz et al., 2008). Antisense digoxygenin-labeled riboprobes were 
transcribed with T7, T3, or SP6 (Roche) following linearization of template DNA.   
Whole Mount RNA In Situ Hybridization 
Whole mount in situ hybridization was performed essentially as previously 
described(Nagy, 2003).  Antisense digoxygenin-labeled riboprobes were 
transcribed for Hand1 and Tbx5.  For double in situ hybridization modifications 
were made as previously described (Ishii et al., 2007).  Briefly, a riboprobe for 
Hand1 was detected using anti-digoxigenin antibody and NBT/BCIP substrate. 
After the removal of the antibody by incubating twice with glycine-HCl (pH 2.2), 
the Mlc2A probe was detected using anti-fluorescein antibody and INT/BCIP 
substrate.  After color development was completed, embryos were fixed with 4% 
paraformaldehyde in phosphate-buffered saline (PBS). 
Primary Epicardial Culture 
 Primary epicardial cultures were isolated and cultured as previously 
described for both WT and H2CKO (Rhee et al., 2009).  E11.5 hearts were 
explanted for 48 hours before removal.  Isolated epicardial cells were cultured for 
an additional 48 hours before RNA isolation or immunocytochemistry. 
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Immunocytochemistry 
 Primary epicardial cultures were fixed in 4% PFA for 10 minutes, washed, 
and incubated in 0.1% Sodium Borohydride for 30 minutes.  Cells were 
permeabilized with 0.15% Trition, blocked with 2% normal serum, and incubated 
with primary antibodies for Fn1 (Abcam).  Secondary antibodies were conjugated 
with Alexa 488 (Molecular Probes) and counter stained with DAPI.  
 
Immunohistochemistry 
Embryos were fixed in 4% PFA overnight then embedded in paraffin or 
cryoprotected and sectioned at 7mm.  Antibody staining for α-SMA (Sigma), 
Tyrosine Hydroxylase, and Tubb3 (Abcam) was done as previously described on 
paraffin embedded samples (Snider et al., 2008).  Frozen sections were washed 
in PBS, blocked in 1.5% normal serum for 30 minutes followed by a serum-free 
protein block (Dako) for 10 minutes.  Primary antibody for Flk1 (Abcam), Fn1 
(Abcam), pHistone H3 (Abcam), aactivated-Caspase 3 (Promega), α-SMA 
(Sigma),  and GFP (Invitrogen) were incubated at 4OC overnight.  Secondary 
antibodies were conjugated with Alexa 488 or 594 (Molecular Probes).  Alexa 
594-conjugated Phalloidin was used to dye F-Actin filaments (Molecular Probes). 
 
Whole Mount Immunohistochemistry 
 For whole-mount immunohistochemistry with Rat α-CD31 (BD 
Pharmingen, Cat# 550274), embryos were collected in 1X PBS and were fixed 
overnight in 4% PFA.   Embryos were rinsed in 1X PBS three times and 
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dehydrated through a methanol gradient (25%, 50%, 75%, 100% twice), and 
stored at –20OC until use. Embryos were bleached for 1 hour on ice in 5% 
H2O2/methanol. Embryos were then rinsed in 100% methanol for 10 minutes and 
rehydrated thru a methanol gradient. The remainder of steps were then carried 
out at 4’ on a nutator. Embryos were washed three times in PBTXX (1X PBS, 1% 
Triton X-100) and then blocked in PBSMT (1X PBS, 2% nonfat instant skim milk, 
0.5% Trition X-100) for 2 hours. The blocking solution was then removed and 
embryos were incubated overnight in PBSMT with 1’ antibody (1:250).   The 
following day, embryos were washed five times in PBSMT for 1 hour each.  
Embryos were then incubated in PBSMT with Goat α-RAT (ABCAM, Cat# 
AB7097) 2’ antibody (1:250). The following day embryos were washed five times 
in PBSMT for 1 hour each. Embryos were then washed twice in PBTXX for 10 
minutes at room temperature. Embryos were developed using DAB substrate kit 
(VECTOR, SK-4100).   
 
Clearing of Embryos 
Hand1LacZ/+ mice, Hand1EGFPCreΔNeo/+ mice, and PECAM 
immunohistochemistry stained embryos were cleared following dehydration 
washing embryos in BABB (Benzyl Benzoate:Benzyl Alcohol at a 2:1 
concentration). Embryos were photographed with bright field illumination. 
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Quantitative RT-PCR 
 Total RNA was isolated from flash-frozen E12.5 hearts or primary 
epicardial cultures using the High Pure RNA Tissue or Isolation Kit (Roche).  
Total RNA served as a template to generate cDNA using the Transcriptor First 
Strand cDNA Synthesis Kit (Roche) or WGA1 Whole Genome Amplification Kit 
(Sigma).  For quantitative real-time PCR, cDNA was amplified using Lightcycler 
480 Probes Master (Roche). Target gene specific assays were were designed in 
accordance with the UPL probe library (Roche).  Relative gene expression was 
determined by using standard curves and normalized to GAPDH.  3-6 samples 
were collected per assay.  Differences between groups were examined for 
statistical significance using the Student’s t-test.  P values of <0.05 were 
regarded as significant.  
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